[{"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM ALX Oncology Names New CFO; Shares Rise MT Newswires Wed, Jan 22, 2025, 9:24 PM In This Article: ALXO ALX Oncology Holdings (ALXO) said Wednesday it has appointed Harish Shantharam to the office of chie PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-22T21:24:01", "sentiment": {"score": 0.08784887008368969, "confidence": 0.09793687611818314, "probabilities": {"positive": 0.09793687611818314, "negative": 0.010088006034493446, "neutral": 0.8919750452041626}}, "embedding": [-0.08572470396757126, -0.22977395355701447, 0.06523600220680237, 0.01040161494165659, 0.014987283386290073, 0.00718864519149065, -0.03830140456557274, -0.022398443892598152, -0.07991566509008408, 0.047086916863918304, 0.03281175345182419, 0.13663053512573242, 0.056296076625585556, -0.030137769877910614, -0.1287153661251068, 0.15935246646404266, 0.16616497933864594, -0.06903469562530518, -0.17811712622642517, 0.14610068500041962, -0.07294820994138718, -0.07546171545982361, 0.09698418527841568, -0.0010056316386908293, 0.03734147176146507, 0.030286461114883423, -0.19431264698505402, 0.028631823137402534, -0.03866308555006981, -0.016978828236460686, 0.011549719609320164, 0.09153802692890167, -0.006341723725199699, -0.07233131676912308, 0.027813278138637543, -0.0411221869289875, 0.09989923983812332, 0.1341339647769928, 0.042193178087472916, 0.06498578190803528, 0.1806507259607315, -0.26439622044563293, -0.03638593107461929, 0.15047717094421387, -0.12172887474298477, -0.14650361239910126, -0.025769740343093872, 0.01651836186647415, 0.16900143027305603, 0.1788857877254486, -0.10813929885625839, -0.1302914023399353, 0.028698135167360306, 0.05532045289874077, -0.11886750906705856, -0.023246293887495995, -0.06918425858020782, -0.09002365171909332, 0.03702734410762787, -0.06944064050912857, -0.12684689462184906, -0.09302756190299988, -0.0030642475467175245, 0.24168811738491058, 0.029991619288921356, 0.032014038413763046, -0.04550705477595329, -0.06311993300914764, -0.10532621294260025, -0.1701311320066452, 0.07356297224760056, -0.01893976330757141, 0.03530297428369522, 0.13099023699760437, 0.10276491940021515, 0.12649939954280853, 0.22335787117481232, -0.02719663828611374, 0.14178195595741272, -0.11271200329065323, -0.01793362945318222, 0.0041543059051036835, 0.24552249908447266, -0.0129805076867342, -0.04794173315167427, -0.08143928647041321, -0.038473423570394516, -0.028931302949786186, 0.0026225729379802942, -0.0853138417005539, 0.01500355638563633, -0.023857472464442253, 0.04551909118890762, -0.020172419026494026, -0.1051354631781578, -0.04396491125226021, -0.06099798157811165, 0.09180346131324768, -0.2064976990222931, 0.10645230859518051, 0.02153816819190979, 0.008950427174568176, -0.1298774629831314, -0.0027922121807932854, -0.07868748158216476, -0.044703077524900436, -0.07897823303937912, 0.09622259438037872, -0.10256056487560272, 0.010486215353012085, 0.03051682375371456, 0.11297526210546494, -0.0033886779565364122, -0.19640597701072693, -0.13332292437553406, 0.12233134359121323, -0.12680795788764954, -0.21719308197498322, 0.015292002819478512, -0.09886441379785538, -0.05293766409158707, 0.021276265382766724, -0.19456449151039124, 0.05744875967502594, 0.01935335248708725, -0.023005211725831032, -0.08182479441165924, 1.1322748030888106e-32, -0.11469140648841858, 0.07155654579401016, 0.10215052962303162, -0.09250422567129135, 0.03557323291897774, 0.009115765802562237, 0.009576024487614632, -0.18765254318714142, -0.18415267765522003, -0.06111643463373184, -0.16011463105678558, 0.27323803305625916, -0.09673111885786057, -0.04041916877031326, -0.0762697383761406, -0.19705042243003845, -0.005032219458371401, 0.10430383682250977, 0.054782990366220474, 0.027701493352651596, 0.12151506543159485, -0.05687360465526581, 0.02170574851334095, -0.004423859529197216, 0.1015651598572731, 0.2392052561044693, 0.16047978401184082, -0.1232992485165596, 0.04510565474629402, 0.092375747859478, -0.167562335729599, 0.11953962594270706, -0.0033839079551398754, -0.13238973915576935, -0.11986204236745834, 0.07848990708589554, -0.22724206745624542, -0.08193673938512802, -0.04475880786776543, -0.07607457786798477, 0.09786723554134369, 0.0970633327960968, -0.07306374609470367, 0.04674271494150162, -0.012857259251177311, -0.06146516650915146, -0.054591961205005646, -0.055483948439359665, 0.2719610035419464, -0.15976056456565857, 0.0421091727912426, 0.013065182603895664, -0.1378437578678131, -0.026218336075544357, 0.028866659849882126, -0.06577003747224808, -0.18418480455875397, -0.08290470391511917, 0.24299459159374237, -0.03284719958901405, 0.0652707889676094, -0.004328221082687378, -0.08896517753601074, 0.1304178237915039, -0.18290700018405914, -0.036742258816957474, -0.050616126507520676, -0.11700549721717834, -0.1278003752231598, 0.08470319956541061, 0.09060455858707428, -0.027456795796751976, 0.1366899609565735, 0.11159133911132812, -0.14794807136058807, 0.08986557275056839, -0.0618693009018898, -0.07940181344747543, 0.12819348275661469, 0.070853091776371, 0.1991187185049057, -0.04037761315703392, 0.14454689621925354, 0.15648633241653442, -0.0746837928891182, 0.026573777198791504, -0.024758024141192436, -0.0033672477584332228, -0.10299991071224213, 0.10920285433530807, -0.05150001496076584, 0.03574955835938454, 0.03603356331586838, 0.018551457673311234, -0.012421581894159317, -1.4291617705627154e-32, -0.022860173135995865, -0.062168676406145096, -0.027455057948827744, -0.17602534592151642, -0.05719616636633873, 0.06040516868233681, -0.10969918221235275, 0.16696128249168396, 0.16199776530265808, 0.05927635729312897, 0.187819704413414, 0.1646665632724762, -0.05608757585287094, -0.025647256523370743, -0.07608150690793991, 0.009722101502120495, 0.1847950518131256, -0.12050625681877136, -0.1121392771601677, -0.122701495885849, -0.027443725615739822, 0.1994069218635559, -0.19582174718379974, 0.17908497154712677, -0.02874065563082695, -0.06098765879869461, 0.1206885278224945, 0.192545086145401, 0.053031425923109055, 0.028197944164276123, -0.22654762864112854, -0.0006543690687976778, -0.1868729144334793, 0.13015316426753998, 0.05572671443223953, 0.09117614477872849, 0.1052171140909195, 0.010865372605621815, 0.0035580857656896114, 0.10659178346395493, 0.1531279981136322, -0.09590829163789749, -0.04825358837842941, 0.031832173466682434, 0.11917509138584137, 0.14919216930866241, -0.15763448178768158, -0.10680174082517624, 0.08296128362417221, -0.015333869494497776, -0.07288992404937744, 0.09538879990577698, -0.09100038558244705, 0.06369131058454514, -0.03317536041140556, 0.1821950227022171, -0.07470809668302536, -0.04357846826314926, -0.03189653903245926, -0.06487222015857697, 0.011824997141957283, 0.23527775704860687, -2.4948518330347724e-05, -0.1701517105102539, -0.0754169151186943, 0.20776230096817017, -0.08167670667171478, -0.12792739272117615, -0.006654663011431694, 0.08747954666614532, 0.07488064467906952, -0.005048638675361872, -0.2429007738828659, -0.2152792513370514, 0.12759965658187866, 0.16952037811279297, 0.02431170456111431, 0.0036083331797271967, -0.20216897130012512, 0.11252965778112411, 0.0997438058257103, -0.04260563105344772, 0.017267387360334396, -0.00612711813300848, 0.07962612062692642, 0.07176684588193893, 0.1378067135810852, 0.011375370435416698, -0.1557011604309082, -0.021708032116293907, -0.13529306650161743, -0.3023260533809662, -0.2345283329486847, 0.044029559940099716, -0.06334611028432846, -9.953044610711004e-08, 0.010741647332906723, -0.03554437309503555, 0.01601186953485012, -0.02689209394156933, 0.041651856154203415, 0.05898897722363472, -0.08635178953409195, -0.03726821020245552, 0.07378631085157394, 0.140420064330101, 0.18447214365005493, 0.04814649000763893, -0.027506351470947266, 0.0031433328986167908, 0.04910135269165039, 0.08272194117307663, -0.025318102911114693, 0.09091976284980774, 0.009186860173940659, -0.1335921585559845, -0.10625535994768143, 0.20269931852817535, 0.19988544285297394, -0.009879094548523426, 0.03347036615014076, 0.034196916967630386, -0.06469698995351791, 0.011459918692708015, 0.07257314771413803, 0.11956571787595749, -0.034756507724523544, 0.07182898372411728, -0.18019208312034607, -0.1401611715555191, -0.00320239900611341, 0.008824505843222141, -0.02658407762646675, 0.04429275915026665, 0.17188139259815216, 0.029288481920957565, 0.04974599927663803, 0.056958697736263275, 0.03971598297357559, 0.08567056804895401, 0.0010846813675016165, 0.07241557538509369, -0.08693108707666397, -0.1455722600221634, 0.20809392631053925, -0.10809678584337234, 0.052611883729696274, -0.024398427456617355, 0.06145858019590378, -0.07696662098169327, -0.047991957515478134, 0.07147038727998734, -0.062138188630342484, -0.19088782370090485, 0.0007858991739340127, -0.03868524357676506, 0.07751038670539856, -0.33479973673820496, 0.14174191653728485, 0.07627356052398682], "changes": {"1wk": -18.888884620901866}}, {"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM UBS Cuts Price Target on ALX Oncology Holdings to $2.20 From $4, Keeps Buy Rating MT Newswires Mon, Jan 27, 2025, 3:59 PM In This Article: ALXO ALX Oncology Holdings (ALXO) has an average rating of overweight and mean price target of $4.04, acc PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-27T15:59:33", "sentiment": {"score": 0.06470084004104137, "confidence": 0.08105284720659256, "probabilities": {"positive": 0.08105284720659256, "negative": 0.016352007165551186, "neutral": 0.9025951027870178}}, "embedding": [0.004681996535509825, 0.022458022460341454, 0.011586797423660755, 0.11904316395521164, 0.10713241994380951, -0.01897512376308441, 0.008231027983129025, -0.023897629231214523, 0.003273053327575326, 0.04820140451192856, -0.01449046190828085, -0.007853255607187748, 0.12888957560062408, -0.03339049592614174, -0.08655571937561035, 0.16785061359405518, 0.2021307647228241, -0.03554537519812584, -0.132531076669693, 0.1501503735780716, 0.02942901849746704, -0.00834066141396761, 0.14451266825199127, 0.09583864361047745, 0.15985551476478577, -0.11938789486885071, -0.07060786336660385, -0.020030835643410683, -0.049452632665634155, -0.05556969344615936, 0.06779436767101288, -0.014702335931360722, -0.04528554528951645, -0.1423346996307373, 0.029568931087851524, -0.15600866079330444, 0.00639362633228302, 0.04268525540828705, -0.042119044810533524, 0.0732497125864029, 0.19636540114879608, -0.08410169184207916, -0.13242775201797485, 0.2436448633670807, -0.14856524765491486, -0.1378447413444519, -0.08316441625356674, 0.1843051016330719, 0.16078545153141022, 0.2836655378341675, -0.11592463403940201, -0.06775177270174026, -0.039329566061496735, 0.03149014338850975, -0.060580212622880936, -0.09214795380830765, -0.2044038325548172, 0.020498141646385193, 0.09210439026355743, -0.08139068633317947, -0.07107675820589066, -0.1577381044626236, 0.04642680287361145, 0.20094719529151917, 0.06368502229452133, 0.061086468398571014, -0.06823033094406128, -0.13502906262874603, -0.146635040640831, -0.04881451651453972, 0.10417409241199493, -0.038908589631319046, 0.16715535521507263, 0.08227451890707016, 0.11486142873764038, 0.1264847218990326, 0.20589947700500488, -0.06801404803991318, 0.028568321838974953, -0.0255713053047657, -0.007533262018114328, -0.10577122867107391, 0.09316276758909225, -0.041496168822050095, -0.03021092526614666, -0.16231758892536163, 0.1297225058078766, 0.00010118677892023697, 0.03239547461271286, -0.004644057713449001, 0.10711407661437988, -0.09674136340618134, 0.038442596793174744, 0.00944671779870987, -0.10939274728298187, -0.08737457543611526, -0.024341393262147903, 0.04977767914533615, -0.18098008632659912, 0.024072693660855293, 0.09244676679372787, -0.08238918334245682, -0.09718899428844452, 0.0390094518661499, -0.0991111621260643, -0.12126391381025314, -0.08563265204429626, 0.06133006885647774, -0.07118728011846542, 0.06946555525064468, -0.0673626959323883, 0.04864225909113884, -0.09152408689260483, -0.1713421493768692, -0.12911789119243622, 0.03466784954071045, -0.03809406980872154, -0.31712526082992554, 0.018628312274813652, -0.14102968573570251, -0.07959487289190292, 0.0002001417160499841, -0.14846347272396088, 0.08871409296989441, -0.017996832728385925, -0.034107860177755356, -0.15418562293052673, 1.2873414628086773e-32, -0.0974927619099617, 0.01790488511323929, -0.011123746633529663, -0.24431248009204865, -0.028052225708961487, 0.003634112887084484, 0.030790310353040695, -0.14308208227157593, -0.24697250127792358, -0.07399448752403259, -0.1720559298992157, 0.25970834493637085, 0.005347293335944414, 0.09321976453065872, 0.03784928098320961, -0.3095111846923828, 0.038924723863601685, 0.05860451981425285, 0.10285192728042603, 0.13171394169330597, 0.004355404060333967, -0.13108082115650177, -0.035453010350465775, 0.05625036731362343, -0.0543905645608902, 0.2555145025253296, 0.04489830508828163, -0.15065336227416992, 0.034704823046922684, 0.030780496075749397, -0.266722708940506, 0.112310491502285, -0.03721829131245613, -0.16272155940532684, -0.09361185133457184, 0.09384718537330627, -0.17497555911540985, 0.017697865143418312, 0.027493758127093315, -0.12934020161628723, -0.020826777443289757, 0.17161229252815247, -0.014878138899803162, 0.004023187328130007, 0.12425680458545685, -0.0305321104824543, -0.08366453647613525, -0.04826970770955086, 0.052187565714120865, -0.17172719538211823, -0.030296005308628082, 0.02589639090001583, -0.08450977504253387, -0.07030940800905228, -0.1440441906452179, -0.07182736694812775, -0.18359063565731049, -0.08962032943964005, 0.10126793384552002, 0.0024285970721393824, 0.13625401258468628, 0.08702778071165085, 0.03199043497443199, 0.09877976775169373, -0.30279237031936646, 0.11114026606082916, -0.04911142215132713, -0.1388436257839203, -0.14719387888908386, 0.1308276206254959, 0.1234126016497612, 0.060774754732847214, 0.2174227237701416, 0.0027881537098437548, -0.1205148845911026, 0.107037253677845, -0.028356384485960007, -0.0818553939461708, 0.18679378926753998, 0.094732366502285, 0.04751025512814522, -0.10308457165956497, 0.17656996846199036, -0.029747817665338516, -0.02777523547410965, -0.0478348508477211, -0.08631119877099991, 0.09023607522249222, -0.08918673545122147, 0.12991826236248016, 0.02325093001127243, 0.006408886518329382, -0.10239239782094955, 0.032153643667697906, 0.10878148674964905, -1.5399672476174829e-32, -0.011966153047978878, 0.008068576455116272, 0.1694401055574417, -0.09643687307834625, -0.01449658814817667, 0.05405833572149277, -0.11497525125741959, 0.21423718333244324, 0.19180434942245483, 0.12711213529109955, 0.0882335975766182, 0.19867143034934998, -0.1462312787771225, 0.11218157410621643, -0.036159858107566833, -0.06067562848329544, 0.11988755315542221, -0.08921647071838379, 0.03723326697945595, -0.2231648564338684, -0.04143798351287842, 0.268778920173645, -0.1900213211774826, 0.2685874104499817, -0.06933282315731049, -0.07112298160791397, 0.1830921322107315, 0.05990586429834366, 0.07215647399425507, -0.09879057109355927, -0.20153062045574188, 0.07772356271743774, -0.17315751314163208, 0.0959935188293457, 0.01760626584291458, 0.15073655545711517, 0.09646320343017578, 0.07409799098968506, 0.015334711410105228, 0.026231786236166954, 0.14154395461082458, -0.0772068127989769, -0.08384585380554199, 0.011443504132330418, 0.20091693103313446, 0.10160356760025024, -0.08877739310264587, 0.08045691251754761, 0.09454648941755295, -0.01594407856464386, -0.06264211982488632, 0.055641815066337585, -0.036314114928245544, 0.14535918831825256, -0.2041553258895874, 0.08867906779050827, -0.09210854023694992, -0.0457465723156929, -0.030329234898090363, -0.06135067343711853, 0.024331625550985336, 0.2833474278450012, -0.07921396940946579, -0.07093160599470139, -0.12439921498298645, 0.13290545344352722, 0.01024955790489912, -0.12343581765890121, -0.053191863000392914, 0.06874003261327744, 0.07150278240442276, -0.04494263231754303, -0.12611058354377747, -0.14841130375862122, 0.08961570262908936, 0.10998966544866562, -0.033750008791685104, -0.008207323029637337, -0.1212359294295311, 0.10751999169588089, 0.09116430580615997, -0.04568085819482803, 0.09845568984746933, -0.012937869876623154, 0.025433510541915894, 0.008998622186481953, 0.05851833149790764, 0.009547092020511627, -0.2570574879646301, 0.05753321200609207, -0.18823643028736115, -0.26522064208984375, -0.1566833257675171, -0.004875667858868837, -0.1828872710466385, -9.959917690594011e-08, 0.024008136242628098, 0.01604747399687767, 0.11380067467689514, 0.0992436632514, 0.027456382289528847, 0.17102940380573273, -0.053432974964380264, 0.06495573371648788, 0.13822680711746216, 0.1552392542362213, 0.10089919716119766, -0.050832223147153854, -0.09565514326095581, 0.007568721659481525, -0.0802159458398819, 0.003733627498149872, -0.006284452974796295, 0.11655855178833008, 0.10953376442193985, -0.12345241755247116, 0.01819824054837227, 0.15524061024188995, 0.1089758351445198, 0.03513282164931297, 0.09997594356536865, 0.15713945031166077, -0.04647934436798096, 0.05156749114394188, 0.08255832642316818, 0.15959130227565765, -0.0453048013150692, -0.023805653676390648, -0.14325569570064545, -0.08846636861562729, 0.06070462241768837, -0.04212108254432678, -0.03846476599574089, 0.0770544782280922, 0.129407599568367, 0.0377032496035099, 0.047774843871593475, -0.024112418293952942, 0.07302569597959518, 0.01442174706608057, -0.05886654183268547, 0.08947388827800751, -0.25397196412086487, -0.1770148128271103, 0.19985373318195343, -0.12771494686603546, 0.11542168259620667, -0.11999264359474182, 0.004742875695228577, -0.02664959616959095, -0.056511491537094116, -0.05333646759390831, -0.04963480308651924, -0.09136208146810532, -0.08368699252605438, 0.0011523767607286572, 0.21415410935878754, -0.33719682693481445, 0.020351363345980644, 0.16730861365795135], "changes": {"1wk": -6.109319138611277}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer ALX Oncology Thu, Jan 23, 2025, 4:00 PM 8 min read In This Article: ALXO ALX Oncology Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights e vorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a prospective randomized trial Greatest benefit observed among patients with confirmed HER2-positive cancer, as demonstrated by either fresh biopsy or ctDNA HER2-expression, with confirmed ORR of 48.9% and mDOR of 15.7 months vs. 24.5% ORR and mDOR of 9.1 months in the control group, and a PFS Hazard Ratio of 0.64 Company to host conference call and investor webcast today at 1:00 PM PT/4:00 PM ET SOUTH SAN FRANCISCO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d or the \u201cCompany\u201d) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives, announced positive updated data from the ASPEN-06 Phase 2 clinical trial demonstrating that the company\u2019s investigational CD47-blocker evorpacept generates a durable clinical response with a well-tolerated safety profile among patients with previously treated HER2-positive advanced gastric cancer (GC) or gastroesophageal junction (GEJ) cancer. The updated results, which build upon previously announced topline results, will be shared today in an oral presentation (Abstract #332) at the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco. \u201cThe updated data from the ASPEN-06 trial highlight the potential clinical utility of CD47 inhibition from evorpacept in combination with trastuzumab, ramucirumab and paclitaxel in patients with previously treated HER2-positive gastric cancer,\u201d said Kohei Shitara, M.D., Director of the Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan and the study\u2019s presenter. \u201cOverall, the findings suggest that evorpacept generates durable and clinically meaningful anti-tumor activity in this population of patients who had previously received a HER2-targeted agent, with the largest benefit among those patients with confirmed HER2-positive disease.\u201d ASPEN-06 is a randomized, multi-center, international trial (NCT05002127) evaluating evorpacept, ALX Oncology\u2019s investigational CD47-blocking therapeutic that uniquely combines a high-affinity CD47-binding domain with an inactivated proprietary Fc domain, in combination with trastuzumab, CYRAMZA\u00ae (ramucirumab) and paclitaxel (collectively, ETRP) against trastuzumab, ramucirumab and paclitaxel (TRP) alone for the treatment of patients with HER2-positive gastric/GEJ cancer, where all patients had received an anti-HER2 agent in prior lines of therapy. Patients were enrolled with either archival or fresh HER2-positive biopsies. Continua a leggere The trial\u2019s primary endpoints were investigator-assessed overall response rate (ORR) in the intent-to-treat (ITT) population and in the population of patients with fresh HER2-positive biopsies, compared to both internal control (TRP) and historical control (ramucirumab and paclitaxel, or RP). Key secondary endpoints were safety, duration of response (DOR), progression-free survival (PFS) and overall survival (OS). The updated dataset being presented today includes results from a December 2, 2024 data cut, including an analysis that assessed patients with HER2-positive tumors via circulating tumor DNA (ctDNA) at baseline. Overall survival data were not yet mature at the time of data cut. Updated trial results to be shared today at 2025 ASCO GI include: Primary endpoints (December data cut): ITT patient population ORR (N=127) : Evorpacept plus TRP (ETRP) demonstrated an ORR of 41.3% compared to 30% for RP historical control and 26.6% for TRP control. Fresh HER2-positive biopsy patient population ORR (n=48) : ETRP demonstrated an ORR of 59.1% compared to 30% for RP historical control and 23.1% for TRP control. In the ITT population, ETRP demonstrated a median DOR (mDOR) of 15.7 months and a median PFS (mPFS) of 7.5 months compared to an mDOR of 9.1 months and mPFS of 7.4 months in the TRP control group, with a PFS Hazard Ratio (HR) in this population of 0.77. In patients with fresh HER2-positive biopsies, ETRP demonstrated an mDOR of 15.7 months and mPFS of 9.5 months compared to an mDOR of 14.5 months and 7.1 months in the TRP control group, with a PFS HR of 0.62. In patients with confirmed HER2-positive expression as determined by either fresh biopsy or ctDNA HER2-positivity (n=96), the addition of evorpacept to TRP resulted in a 48.9% ORR, an mDOR of 15.7 months and mPFS of 7.5 months, compared to 24.5% ORR, an mDOR of 9.1 months and mPFS of 6.7 months in the TRP control group, with a PFS HR of 0.64. Evorpacept plus TRP was generally well tolerated, with the incidence of adverse events in the evorpacept population consistent with those in TRP control. \u201cThe results from this trial tell a clear story that when a cancer cell is expressing HER2, evorpacept can combine with a regimen containing an anti-HER2 antibody such as trastuzumab to improve upon the activity you would expect from that regimen alone,\u201d said Alan Sandler, M.D., Chief Medical Officer at ALX Oncology. \u201cThis is evidenced by the near doubling of PFS at one year among the patients with HER2-positivity confirmed via either fresh biopsy or ctDNA who received ETRP vs control. Additionally, the analysis of this patient population affirms HER2-expression is a key biomarker for evorpacept efficacy and validates the strategy behind evorpacept\u2019s novel design.\u201d The updated ASPEN-06 data add to positive findings from a Phase 1b/2 trial recently presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). These findings suggested that patients with heavily pretreated HER2-positive advanced breast cancer had anti-tumor activity from CD47 inhibition with evorpacept when it is combined with a HER2-targeted agent. \u201cThe dataset shared today from the ASPEN-06 randomized clinical trial suggests durable clinical benefit driven by evorpacept and a differentiated safety profile \u2013 a first for any CD47 blocker,\u201d said Jason Lettmann, Chief Executive Officer at ALX Oncology. \u201cBased on the collective clinical data we\u2019ve now seen across patients with HER2-positive gastric and breast cancers, we believe evorpacept is working as designed in combination with antibodies when there is HER2 expression, even when patients had been previously treated with other HER2-directed therapies. We look forward to sharing the updated ASPEN-06 data with the FDA and are confident in our path to pursue evorpacept as a therapeutic option for patients.\u201d A copy of the 2025 ASCO GI presentation will be available in the \u201cPublications\u201d section of the ALX Oncology website following the presentation. The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to evorpacept for the second-line treatment of patients with HER2-positive gastric or GEJ carcinoma. Additionally, both the FDA and European Commission have granted Orphan Drug Designation for this indication. Company Conference Call and Webcast on January 23 at 1:00 PM PT/4:00 PM ET ALX Oncology will host a conference call and webcast today at 1:00 PM PT/4:00 PM ET to review the updated ASPEN-06 data. The event will be webcast live and a replay will be available after the call by visiting the \u201cInvestors\u201d section of ALX Oncology\u2019s website and selecting \u201cEvents and Presentations\u201d. Date & Time: Thursday, January 23, 1:00 PM PT/4:00 PM ET Webcast Access: https://edge.media-server.com/mmc/p/ipy66o44 About ALX Oncology ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology . Cautionary note regarding forward-looking statements This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements include statements regarding future results of operations and financial position, business strategy, product candidates, planned preclinical studies and clinical trials, results of clinical trials, research and development costs, regulatory approvals, timing and likelihood of success, plans and objects of management for future operations, as well as statements regarding industry trends. Such forward-looking statements are based on ALX Oncology\u2019s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause ALX Oncology\u2019s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These and other risks are described more fully in ALX Oncology\u2019s filings with the Securities and Exchange Commission (SEC), including ALX Oncology\u2019s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents ALX Oncology files with the SEC from time to time. Except to the extent required by law, ALX Oncology undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Investor Relations Contact: Elhan Webb, CFA, IR Consultant ewebb@alxoncology.com Media Contact: Audra Friis, Sam Brown, Inc. audrafriis@sambrown.com (917) 519-9577 Visualizza commenti Condizioni e Informativa sulla privacy Privacy Dashboard Storie consigliate", "symbol": "ALXO", "date": "2025-01-23T16:00:00", "sentiment": {"score": 0.26448283437639475, "confidence": 0.2759298086166382, "probabilities": {"positive": 0.2759298086166382, "negative": 0.011446974240243435, "neutral": 0.7126232385635376}}, "embedding": [-0.00512943509966135, -0.1272602379322052, -0.08341804146766663, -0.016103297472000122, 0.032894883304834366, -0.12106633186340332, -0.1050184965133667, 0.14397747814655304, 0.16003042459487915, -0.006772116757929325, -0.0343213714659214, 0.06430190801620483, 0.007403364405035973, -0.05787739157676697, -0.03296259045600891, 0.2001880705356598, 0.11138452589511871, 0.02103601023554802, -0.07857160270214081, 0.06011652946472168, 0.028126217424869537, -0.07592030614614487, 0.2120550572872162, 0.11954428255558014, -0.11179974675178528, -0.051648933440446854, -0.08894146978855133, 0.013239791616797447, -0.1326252520084381, -0.03236322104930878, 0.032124292105436325, 0.025944342836737633, -0.009272742085158825, 0.030614376068115234, 0.0242597758769989, -0.020607229322195053, -0.08456257730722427, 0.1105826199054718, -0.12495027482509613, -0.060614705085754395, -0.026227107271552086, -0.0709061473608017, -0.057127222418785095, 0.01926703006029129, -0.0766770988702774, -0.1627880036830902, -0.07426987588405609, 0.05486864224076271, 0.0042326441034674644, 0.2542770206928253, -0.0377589613199234, 0.06129453331232071, -0.05113974213600159, 0.0882982462644577, 0.016086693853139877, 0.026284828782081604, -0.06565174460411072, 0.04745914041996002, 0.06012647598981857, -0.06505705416202545, 0.0789974182844162, -0.06393139064311981, 0.05435120686888695, 0.06440373510122299, 0.006935290992259979, -0.10199254751205444, -0.04591905325651169, -0.025178948417305946, -0.03867562860250473, 0.0035459380596876144, -0.040153615176677704, -0.04730799421668053, 0.06738549470901489, 0.144476056098938, 0.06259308755397797, 0.12095615267753601, 0.18590395152568817, 0.05839903652667999, 0.10900998115539551, 0.0049756970256567, 0.08363176882266998, 0.15009579062461853, 0.18614034354686737, 0.02004912495613098, -0.07905856519937515, 0.04739132896065712, -0.020940713584423065, 0.18774829804897308, 0.06591078639030457, -0.04531919211149216, 0.047545842826366425, -0.017495915293693542, 0.015353413298726082, 0.052107930183410645, 0.042626239359378815, -0.17879292368888855, -0.004380628000944853, -0.02011163718998432, 0.06485916674137115, -0.049702852964401245, -0.03410731256008148, 0.005108352284878492, -0.08398085832595825, -0.12484197318553925, -0.02765616774559021, -0.043937914073467255, 0.014094754122197628, -0.021188531070947647, 0.03953512758016586, -0.025901474058628082, 0.08925938606262207, 0.039895132184028625, 0.01936134323477745, -0.0775528997182846, 0.004763227421790361, 0.1783066689968109, -0.0972493439912796, -0.05584638565778732, 0.13059233129024506, -0.04321609437465668, -0.08002735674381256, -0.10735999792814255, 0.019888436421751976, -0.03804108873009682, 0.12669944763183594, 0.056263212114572525, -0.05634598433971405, 1.2025918465974429e-32, -0.10708147287368774, -0.06479766219854355, 0.11256559193134308, 0.07523804157972336, 0.040229834616184235, -0.02744399756193161, 0.05654182657599449, -0.04448767751455307, -0.10193754732608795, 0.023931413888931274, -0.10485119372606277, -0.0903441458940506, 0.10029305517673492, 0.011807946488261223, -0.07879751920700073, -0.05294778570532799, -0.06499924510717392, 0.03673101216554642, -0.14765945076942444, -0.03048730455338955, 0.03340839222073555, -0.015202783048152924, -0.0020420104265213013, -0.005490391980856657, 0.023323561996221542, 0.11229829490184784, -0.010465331375598907, 0.056180234998464584, 0.0035283174365758896, 0.010990767739713192, -0.2147044837474823, 0.03431857004761696, 0.14622806012630463, -0.03202825039625168, -0.03281323239207268, 0.001261778175830841, -0.0597681850194931, -0.10157546401023865, 0.07450833171606064, 0.04879094660282135, -0.07951739430427551, 0.009596714749932289, 0.030788740143179893, -0.04269187152385712, 0.006981842219829559, -0.1981288343667984, -0.0114689776673913, 0.026709508150815964, 0.02035418525338173, 0.03731514513492584, 0.05456245690584183, -0.016398698091506958, -0.03014303371310234, 0.05697740614414215, -0.07261205464601517, -0.00030852342024445534, -0.17725244164466858, 0.026351213455200195, 0.1491294801235199, 0.10525932908058167, -0.08934789896011353, 0.02169291116297245, -0.025832736864686012, -0.00796328391879797, -0.017561282962560654, 0.09998317807912827, 0.029694516211748123, -0.18066070973873138, -0.08572850376367569, 0.10793231427669525, -0.09299687296152115, 0.03193984180688858, 0.191852867603302, 0.08995979279279709, 0.09110763669013977, -0.08483816683292389, 0.10616922378540039, 0.07172749936580658, 0.02831343375146389, 0.12993527948856354, -0.011155282147228718, -0.09584659337997437, -0.11069418489933014, 0.1578165590763092, -0.0773426741361618, -0.14774392545223236, -0.07877661287784576, -0.08085215836763382, -0.12182173132896423, 0.14102841913700104, 0.13091805577278137, 0.005726886913180351, 0.026141485199332237, 0.10555911064147949, 0.07765033841133118, -1.2746135038515613e-32, -0.027029486373066902, -0.03386799991130829, -0.019491543993353844, -0.07469882816076279, 0.005885852035135031, 0.05727703869342804, -0.016193682327866554, -0.11532890796661377, 0.06389399617910385, -0.23503944277763367, 0.1363268494606018, 0.1310274302959442, -0.01690983586013317, -0.008805181831121445, -0.020827358588576317, 0.024399522691965103, -0.03742498531937599, -0.02849534898996353, -0.13311126828193665, 0.04672447592020035, 0.027629727497696877, 0.16007277369499207, -0.12125527858734131, -0.040606312453746796, -0.13372677564620972, 0.08606725931167603, 0.17653679847717285, 0.050941262394189835, 0.18604500591754913, -0.057411789894104004, -0.049848370254039764, 0.15865571796894073, -0.20585061609745026, 0.010614089667797089, 0.05549066886305809, -0.0786719024181366, -0.03992680460214615, -0.15558184683322906, -0.06419815123081207, -0.06870211660861969, 0.05887848138809204, 0.0684981495141983, -0.11242453753948212, -0.024336883798241615, 0.02458399161696434, 0.11526104807853699, 0.1542644500732422, -0.05092347785830498, 0.1467685103416443, -0.04959763586521149, -0.06377116590738297, 0.014549242332577705, -0.0702873095870018, 0.059092313051223755, 0.0812036395072937, 0.017310431227087975, -0.08659164607524872, -0.1483539342880249, 0.0029659788124263287, 0.043667979538440704, -0.034287452697753906, 0.07439352571964264, 0.07546943426132202, 0.04157458618283272, 0.04512236267328262, 0.12122742831707001, 0.07090918719768524, -0.03984075039625168, 0.030799847096204758, 0.02242816612124443, -0.08742707967758179, 0.031317777931690216, -0.06141890585422516, -0.028399160131812096, 0.055793389678001404, 0.11297911405563354, 0.03962096571922302, -0.13402917981147766, -0.03032645955681801, -0.020989619195461273, -0.056376222521066666, -0.029960911720991135, 0.06184876710176468, -0.07534048706293106, 0.17209352552890778, 0.22105491161346436, -0.15688227117061615, 0.05533722788095474, -0.10238008201122284, 0.038879163563251495, -0.0477394163608551, -0.10732284933328629, -0.06833073496818542, 0.03413941711187363, -0.039069563150405884, -9.98243621097572e-08, -0.003585430793464184, 0.002638772130012512, 0.06977749615907669, -0.1760665625333786, -0.018552370369434357, 0.06693814694881439, -0.08418843895196915, 0.11446377635002136, -0.09768001735210419, 0.07746687531471252, 0.12276189774274826, 0.17307038605213165, -0.07999394088983536, -0.15505310893058777, -0.03217356652021408, 0.054224930703639984, -0.022735003381967545, -0.022935153916478157, -0.054269298911094666, -0.02712384983897209, -0.18090343475341797, -0.07658608257770538, 0.04705101251602173, -0.1212083175778389, 0.004130466841161251, -0.023535603657364845, 0.10467643290758133, 0.20035582780838013, 0.03244408592581749, -0.1460018754005432, -0.03442663699388504, -0.048488009721040726, -0.03931738808751106, 0.061834681779146194, 0.023905061185359955, -0.03970955312252045, 0.014139395207166672, 0.05642891675233841, 0.0913352221250534, 0.1558697521686554, 0.051583949476480484, 0.09684354066848755, -0.04121769592165947, -0.004906408488750458, -0.13028135895729065, 0.03853032737970352, -0.05478384345769882, -0.05985427647829056, -0.055432409048080444, -0.13389898836612701, -0.10185466706752777, -0.08227630704641342, -0.042835965752601624, -0.023546481505036354, -0.029466478154063225, 0.06901928037405014, -0.11846120655536652, -0.060192208737134933, 0.03103748708963394, -0.05377427116036415, -0.01895405910909176, -0.12935641407966614, 0.04874974116683006, -0.021510669961571693], "changes": {"1wk": -10.429445250427635}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology Shares Drop 15% Following Positive Phase 2 Faizan Farooque Thu, Jan 23, 2025, 10:44 PM 2 min read In This Article: ALXO ALX Oncology Holdings Inc. ( ALXO , Financials ) saw its stock price fall 15.8% to $1.52 as of 2:32 p.m. GMT-5 on Thursday, despite announcing positive updated results from its ASPEN-06 Phase 2 clinical trial. Warning! GuruFocus has detected 2 Warning Signs with ALXO. Presenting at the 2025 American Society of Clinical Oncology Gastrointestinal tumors Symposium, the findings showed the potential of its experimental CD47-blocking therapy, evorpacept, to enhance outcomes for patients with HER2-positive stomach or gastroesophageal junction tumors. Referred known as ETRP, the study assessed evorpacept versus a control group receiving trastuzumab, ramucirumab, and paclitaxel in combination. Evorpacept attained an overall response rate of 48.9%, almost tripling the 24.5% ORR seen in the control group among patients with verified HER2-positive expression. Median progression-free survival also increased to 7.5 months with evoracept from 6.7 months in the control group. In those with verified HER2-positive expression, the therapy also showed a median duration of response of 15.7 months, much exceeding the 9.1 months attained by the control group. Safety records showed that evorpacept was typically well tolerated and that the adverse event profile matched the control schedule. Presenting the results, Dr. Kohei Shitara highlighted the importance of evorpacept's effectiveness especially for patients who had already had HER2-targeted treatments. Chief Medical Officer of ALX Oncology, Dr. Alan Sandler, underlined the design of the treatment, which combines anti-HER2 antibodies efficiently to improve results. For the second-line treatment of HER2-positive stomach and gastroesophageal junction tumors, the U.S. Food and Drug Administration has assigned Fast Track designation to evoracept. For this indication, the treatment also boasts Orphan Drug Designation from the FDA and the European Commission. Confident in evorpacept's potential as a therapeutic choice for patients, ALX Oncology intends to engage regulatory talks with the FDA. This article first appeared on GuruFocus . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-23T22:44:43", "sentiment": {"score": -0.7303392738103867, "confidence": 0.8510934710502625, "probabilities": {"positive": 0.1207541972398758, "negative": 0.8510934710502625, "neutral": 0.028152333572506905}}, "embedding": [0.10052286833524704, -0.09160269796848297, -0.06945731490850449, 0.033280350267887115, 0.013070712797343731, -0.05700724199414253, 0.004669738933444023, 0.2796374559402466, 0.17973017692565918, 0.021217387169599533, -0.012946788221597672, 0.030543440952897072, 0.06530017405748367, -0.07104459404945374, -0.06115974485874176, 0.17009291052818298, 0.18216535449028015, -0.025301018729805946, -0.046603649854660034, 0.11490897834300995, 0.06808555871248245, -0.11761433631181717, 0.17506864666938782, 0.07886317372322083, -0.0776946023106575, -0.023276668041944504, -0.18296785652637482, 0.030206477269530296, -0.11147129535675049, -0.05584053695201874, 0.055091336369514465, 0.024222634732723236, 0.007943592965602875, -0.04140304774045944, -0.014048054814338684, -0.01785522885620594, -0.08290378004312515, 0.08557931333780289, -0.18192732334136963, -0.025034168735146523, 0.004786763805896044, -0.07828446477651596, -0.10797467827796936, 0.012043285183608532, -0.09215891361236572, -0.14525333046913147, -0.05811662971973419, 0.1085362657904625, -0.0017681585159152746, 0.24860207736492157, -0.01474775094538927, -0.05722846835851669, -0.012488693930208683, 0.07313013076782227, -0.04099198803305626, -0.034826844930648804, -0.06865248829126358, 0.04353215917944908, 0.009320485405623913, -0.018916502594947815, -0.006880526430904865, -0.04127879440784454, 0.04274814948439598, 0.08714526891708374, 0.02561139315366745, -0.037982337176799774, -0.015908509492874146, -0.09527386724948883, -0.029910724610090256, 0.020366158336400986, 0.005834939889609814, -0.07533237338066101, 0.0991179496049881, 0.08183363825082779, 0.035989947617053986, 0.09831046313047409, 0.19862113893032074, 0.06875838339328766, 0.04277515411376953, -0.02993013709783554, 0.08890792727470398, 0.1462874710559845, 0.1368716061115265, 0.018059292808175087, -0.06759016960859299, -0.004113534465432167, 0.0434073880314827, 0.1750280261039734, 0.026422228664159775, -0.007165221497416496, 0.17194712162017822, 0.03218136727809906, -0.0157963614910841, 0.0029013422317802906, 0.12000365555286407, -0.12502023577690125, -0.037642352283000946, -0.06550632417201996, 0.032770540565252304, -0.0037332321517169476, 0.022507790476083755, -0.037242498248815536, -0.102916419506073, -0.15468952059745789, -0.02649998478591442, -0.052364546805620193, -0.002202903851866722, -0.09351542592048645, -0.001817150041460991, -0.021905425935983658, 0.002851078286767006, -0.01957680471241474, -0.005492795258760452, -0.02868369221687317, -0.009660361334681511, 0.2691439390182495, -0.06516709923744202, -0.06199551373720169, 0.14510628581047058, -0.06823782622814178, -0.06550868600606918, -0.09688320755958557, 0.08023858070373535, 2.4429522454738617e-05, 0.125411257147789, 0.06262297183275223, -0.06043047457933426, 1.0388009616793608e-32, -0.12701813876628876, -0.12967495620250702, 0.01573760062456131, -0.04295001178979874, 0.009456465020775795, 0.02555195242166519, 0.059990763664245605, 0.005172695033252239, -0.03167496621608734, -0.013860942795872688, -0.12956839799880981, -0.07500479370355606, 0.10431573539972305, 0.05719383805990219, -0.010340503416955471, -0.09572378545999527, -0.011061443947255611, 0.03075835108757019, -0.09536755084991455, 0.005003523547202349, -0.03950682654976845, -0.03123544156551361, -0.028981061652302742, 0.03398611396551132, -0.03334232419729233, 0.17258349061012268, -0.02796010859310627, 0.021364949643611908, -0.03708930313587189, -0.012636588886380196, -0.15198710560798645, 0.054603248834609985, 0.08728740364313126, -0.057287536561489105, -0.10265794396400452, 0.00977722555398941, -0.08362390100955963, -0.0895375907421112, 0.1007770448923111, 0.005728196352720261, -0.06418430060148239, 0.08232451975345612, 0.032470252364873886, -0.018742896616458893, 0.05575758218765259, -0.17223843932151794, -0.043302908539772034, -0.028992293402552605, -0.0005614152178168297, 0.028553983196616173, 0.04143135994672775, 0.019179651513695717, -0.038769301027059555, -0.051091212779283524, -0.09082753956317902, 0.038077399134635925, -0.2242136001586914, 0.05827673524618149, 0.11131729185581207, 0.09444201737642288, -0.06148248165845871, 0.026820532977581024, 0.019316278398036957, 0.005121929571032524, -0.11831875890493393, 0.10810749232769012, 0.004976650699973106, -0.22029654681682587, -0.10774611681699753, 0.08368651568889618, -0.10870858281850815, 0.05788207799196243, 0.21420802175998688, 0.07959620654582977, 0.10610561072826385, -0.05881413817405701, 0.06001179292798042, 0.10491316020488739, 0.00829506479203701, 0.027955269441008568, -0.03782167285680771, -0.07698025554418564, -0.0425749272108078, 0.122276172041893, -0.03657716512680054, -0.09904704988002777, -0.11666448414325714, 0.03533093258738518, -0.15001171827316284, 0.11360270529985428, 0.12023765593767166, 0.009768093004822731, -0.04420764371752739, 0.12268950045108795, 0.13218817114830017, -1.1397402207740891e-32, -0.02957790344953537, 0.015043963678181171, -0.038892872631549835, -0.051000114530324936, 0.036343760788440704, 0.10596269369125366, -0.07306281477212906, -0.04508600011467934, 0.05386239290237427, -0.15022316575050354, 0.1058618351817131, 0.18547320365905762, -0.03615304082632065, -0.06826912611722946, -0.05094023793935776, -0.014302633702754974, -0.008305441588163376, -0.03902176395058632, -0.07817967236042023, -0.02489113062620163, 0.02412542700767517, 0.15379919111728668, -0.06658516079187393, -0.03480937331914902, -0.09818963706493378, 0.05133684724569321, 0.16686150431632996, 0.020552603527903557, 0.07699207216501236, -0.03934095427393913, -0.07154417783021927, 0.1671498715877533, -0.21841254830360413, 0.05936169624328613, 0.05124150961637497, -0.0978885293006897, -0.08239297568798065, -0.11905357241630554, -0.12473905086517334, -0.015549596399068832, 0.061811573803424835, 0.06292328983545303, -0.00583987683057785, -0.03657260537147522, 0.01960064470767975, 0.1050972267985344, 0.10105693340301514, -0.10261480510234833, 0.16903048753738403, -0.01648598164319992, -0.10133296996355057, 0.013233622536063194, -0.0018546725623309612, 0.041812650859355927, 0.05106731131672859, 0.021427668631076813, -0.0637178122997284, -0.14539067447185516, -0.06437457352876663, 0.06149403378367424, -0.01005928311496973, 0.13703171908855438, 0.12298295646905899, -0.04376329481601715, 0.10134036093950272, 0.11545364558696747, 0.018667075783014297, -0.046394504606723785, 0.037771161645650864, -0.003625784069299698, -0.015524651855230331, -0.007474481128156185, -0.05641491711139679, -0.030197400599718094, 0.06539054214954376, 0.16446027159690857, 0.08942490816116333, -0.19066962599754333, -0.06884278357028961, -0.09374924004077911, -0.07317754626274109, -0.02179982326924801, 0.06404346972703934, -0.03823790326714516, 0.03200865536928177, 0.16439545154571533, -0.16197362542152405, -0.029364794492721558, -0.10769924521446228, 0.07679662108421326, 0.013245140202343464, -0.13318747282028198, -0.019037146121263504, 0.01674554869532585, -0.03439205139875412, -1.0043844866913787e-07, -0.03757635876536369, 0.008502611890435219, 0.08178379386663437, -0.06947419047355652, 0.011012131348252296, 0.03419198840856552, -0.0844031497836113, 0.09516908973455429, -0.11719237267971039, 0.09083864092826843, 0.07482686638832092, 0.13503898680210114, -0.10542754828929901, -0.0727340504527092, -0.07254795730113983, -0.02618296630680561, 0.0343867726624012, 0.04152815043926239, -0.0425788015127182, 0.01642327755689621, -0.1788211315870285, -0.12504255771636963, 0.006264163181185722, -0.1371455192565918, 0.053303271532058716, -0.0383833646774292, 0.13244904577732086, 0.21216794848442078, 0.03819947689771652, -0.0774802714586258, -0.04298141598701477, -0.05909860134124756, -0.027141695842146873, 0.052968550473451614, -0.025886695832014084, -0.043007560074329376, -0.01953699067234993, 0.07229327410459518, 0.084889717400074, 0.17632392048835754, 0.08953830599784851, 0.06297287344932556, 0.08739442378282547, -0.02455947920680046, -0.09897471219301224, 0.016381526365876198, -0.07999983429908752, -0.14552852511405945, 0.04380599036812782, -0.07574068009853363, 0.017774291336536407, -0.08595535159111023, -0.015088405460119247, 0.00546268280595541, -0.06118015572428703, 0.023135362192988396, -0.052497174590826035, -0.09362343698740005, 0.034098122268915176, -0.0785011425614357, -0.07475206255912781, -0.16892437636852264, 0.0841774195432663, 0.010240288451313972], "changes": {"1wk": -19.93865329045797}}, {"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM Sector Update: Health Care MT Newswires Wed, Jan 22, 2025, 11:31 PM In This Article: ALXO Health care stocks eased late Wednesday afternoon, with the NYSE Health Care Index and the Health Ca PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-22T23:31:37", "sentiment": {"score": 0.07601018622517586, "confidence": 0.09352518618106842, "probabilities": {"positive": 0.09352518618106842, "negative": 0.017514999955892563, "neutral": 0.8889598250389099}}, "embedding": [-0.04367246851325035, -0.03754827752709389, 0.13458238542079926, 0.12576158344745636, 0.13615305721759796, -0.029813002794981003, -0.04016906023025513, -0.07012636214494705, -0.20392709970474243, -0.01163120660930872, -0.03477749601006508, 0.15894541144371033, -0.09316692501306534, -0.0030991574749350548, -0.03521537408232689, 0.07073753327131271, 0.05909498780965805, 0.04266666993498802, -0.19249136745929718, 0.22939914464950562, -0.006137656979262829, -0.028023194521665573, 0.05866333842277527, -0.02177230827510357, 0.05696529895067215, 0.1236114427447319, -0.07907126098871231, -0.09666838496923447, -0.0168161541223526, -0.02080330066382885, -0.01729784719645977, -0.014079668559134007, -0.04048347845673561, -0.07545749843120575, -0.030073000118136406, -0.07066365331411362, 0.10713110864162445, 0.06441187858581543, 0.07693859189748764, 0.004416083451360464, 0.2342270165681839, -0.21973785758018494, -0.08945930004119873, 0.13742955029010773, -0.03824016451835632, -0.020246662199497223, -0.029016632586717606, 0.10582245886325836, 0.163277730345726, 0.15569978952407837, -0.1428222358226776, -0.10024122148752213, 0.08349200338125229, 0.010625310242176056, 0.0014758093748241663, -0.08494897931814194, -0.1176285371184349, -0.06615675985813141, 0.02687125653028488, -0.039843734353780746, -0.09002795070409775, -0.14012812077999115, 0.06978458166122437, 0.22149845957756042, -0.009782960638403893, 0.037379052489995956, -0.025981666520237923, -0.014081618748605251, -0.13954077661037445, -0.19167853891849518, 0.020929919555783272, 0.029839467257261276, 0.09542886912822723, -0.0017542476998642087, 0.09244372695684433, 0.06664315611124039, 0.22260664403438568, -0.054966043680906296, 0.110420823097229, -0.12193916738033295, 0.02941368706524372, -0.07253816723823547, 0.06026310846209526, 0.010286527685821056, -0.03182161599397659, -0.0930837094783783, -0.03143260255455971, -0.09616589546203613, -0.03178854659199715, -0.13405390083789825, 0.10507307201623917, -0.0382109060883522, 0.013061962090432644, -0.010368959046900272, 0.030524006113409996, -0.039002057164907455, -0.05815692991018295, 0.02839624509215355, -0.26777148246765137, 0.06012430042028427, 0.05460935831069946, -0.0426185317337513, -0.043046288192272186, 0.10926032066345215, -0.08252987265586853, -0.12434302270412445, -0.17189179360866547, 0.10279123485088348, -0.030916791409254074, 0.15487422049045563, 0.023694247007369995, 0.0670238509774208, -0.023026756942272186, -0.18727505207061768, -0.19088903069496155, 0.0034923842176795006, -0.06483331322669983, -0.2342754453420639, 0.018504146486520767, -0.05416068062186241, 0.0706314742565155, 0.05954406410455704, -0.2407144457101822, 0.026672499254345894, 0.07550731301307678, 0.053907617926597595, -0.011900321580469608, 6.389434808725068e-33, -0.06695836037397385, 0.05277034267783165, 0.01595597341656685, -0.07259631156921387, 0.03396143019199371, -0.011785779148340225, 0.020189102739095688, -0.2171420156955719, -0.032496098428964615, -0.07191414386034012, -0.20994384586811066, 0.35364237427711487, -0.04944169893860817, 0.06544484198093414, -0.12128560990095139, -0.3240206241607666, -0.0735214427113533, 0.0549793541431427, 0.14284303784370422, 0.1469069868326187, 0.13992688059806824, -0.17115531861782074, -0.0026155118830502033, -0.017077341675758362, -0.06239917501807213, 0.18840432167053223, 0.13136443495750427, -0.1815074384212494, -0.0006082915933802724, 0.05185355246067047, -0.177992582321167, 0.1902375966310501, -0.02711421437561512, -0.09972284734249115, 0.017972128465771675, 0.08072206377983093, -0.1937323659658432, 0.013546375557780266, -0.0936598926782608, -0.23228633403778076, -0.04902621731162071, 0.042187102138996124, -0.03078649379312992, 0.06535878032445908, 0.07738383114337921, 0.0008104315493255854, -0.0017661094898357987, -0.08883006870746613, 0.18253052234649658, -0.21640796959400177, -0.00010613860649755225, 0.09435964375734329, -0.1565263271331787, -0.19777590036392212, -0.04302547499537468, -0.006292326375842094, -0.0796472504734993, -0.15922316908836365, 0.045013509690761566, -0.016711153090000153, 0.15940465033054352, 0.03744175657629967, 0.02310272678732872, 0.018472781404852867, -0.22210738062858582, 0.13747067749500275, -0.13555550575256348, 0.020935537293553352, -0.16529406607151031, 0.12636682391166687, 0.12726175785064697, 0.013232934288680553, 0.07959328591823578, 0.05502979829907417, -0.16047917306423187, 0.1737775355577469, -0.08556895703077316, -0.03298604488372803, 0.10436609387397766, 0.006336696911603212, 0.1617089956998825, -0.07565136253833771, 0.25524598360061646, 0.10613527148962021, 0.11490775644779205, 0.09579061716794968, -0.06183134391903877, 0.12271810322999954, 0.05194341018795967, 0.03819333016872406, -0.21666578948497772, 0.012559710070490837, 0.09129980206489563, 0.05088493600487709, -0.00919401552528143, -1.3661248574423133e-32, -0.08205114305019379, -0.017837636172771454, 0.0007601542165502906, -0.0842069536447525, -0.06404560059309006, 0.0002568628697190434, -0.07021357864141464, 0.21423687040805817, 0.21046021580696106, 0.1426728367805481, 0.08634408563375473, 0.07483604550361633, -0.08012738823890686, 0.13313937187194824, 0.014330596663057804, 0.008196457289159298, 0.0353514738380909, -0.13087832927703857, -0.11799397319555283, 0.04883554205298424, 0.022098291665315628, 0.13249792158603668, -0.2126101553440094, 0.35190796852111816, 0.04052615538239479, -0.09025242179632187, 0.09260427206754684, 0.13154253363609314, 0.07285600900650024, -0.13135920464992523, -0.25121012330055237, -0.05020773410797119, -0.1092488244175911, 0.030605508014559746, 0.011918988078832626, 0.08331407606601715, 0.08925727009773254, 0.007354841101914644, 0.009677154943346977, -0.006708422675728798, 0.2220820188522339, -0.19082500040531158, -0.03586268797516823, 0.05702202767133713, 0.1450626403093338, 0.12151540815830231, -0.1587512344121933, 0.04465460032224655, -0.07381896674633026, 0.03796824440360069, -0.06132949888706207, 0.19774022698402405, -0.12339808791875839, 0.15680882334709167, -0.10401737689971924, 0.10988259315490723, -0.10620168596506119, -0.06148383766412735, -0.1457594633102417, -0.03908418491482735, -0.05648202821612358, 0.21172967553138733, -0.09522663801908493, -0.12731240689754486, -0.11573688685894012, 0.025656959041953087, 0.03565976396203041, -0.26427942514419556, 0.08977832645177841, 0.028752794489264488, 0.08500650525093079, -0.08282384276390076, -0.2733137011528015, -0.31681329011917114, 0.14855355024337769, 0.10941165685653687, -0.03925361856818199, 0.0148687232285738, -0.0971752256155014, 0.15801066160202026, 0.18822988867759705, -0.06400585919618607, 0.05724162235856056, -0.042001064866781235, 0.011314257979393005, 0.1127830520272255, 0.1616940200328827, -0.0804964080452919, -0.1754748374223709, 0.052799273282289505, -0.2037775069475174, -0.2056860774755478, -0.27739378809928894, 0.026511183008551598, -0.15827834606170654, -9.969660652586754e-08, 0.09907560795545578, 0.01628640852868557, 0.005882229655981064, -0.016532190144062042, 0.02588932029902935, 0.03259425237774849, -0.18167607486248016, -0.07100363820791245, 0.038528379052877426, 0.14950180053710938, 0.20478278398513794, 0.06730660796165466, -0.07507609575986862, -0.010392767377197742, -0.027557116001844406, 0.015741832554340363, -0.12878121435642242, 0.14954251050949097, 0.02739156223833561, -0.10693705826997757, -0.00279795890673995, 0.16140210628509521, 0.16400717198848724, 0.036026448011398315, 0.11580974608659744, 0.06684013456106186, -0.10011826455593109, -0.05117888003587723, 0.07861801981925964, 0.07622260600328445, -0.0918925479054451, 0.028718141838908195, -0.18100160360336304, -0.09309592097997665, 0.026919562369585037, 0.007956715300679207, 0.05529731512069702, 0.05632467195391655, 0.1877296268939972, 0.0003209838178008795, 0.09169511497020721, 0.022338585928082466, 0.08227113634347916, 0.04262872785329819, -0.04644375666975975, 0.009168670512735844, -0.13178452849388123, -0.1662893444299698, 0.26187509298324585, -0.030313700437545776, -0.015673719346523285, -0.1493242084980011, 0.1272020936012268, -0.08654321730136871, 0.04255317896604538, 0.02207372710108757, -0.06625653058290482, -0.2040800303220749, -0.14018486440181732, 0.14685525000095367, 0.1843421459197998, -0.23070798814296722, 0.09696479886770248, 0.19242607057094574], "changes": {"1wk": -18.888884620901866}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules ALX Oncology Thu, Jan 23, 2025, 12:01 AM 2 min read In This Article: ALXO ALX Oncology SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings, Inc. (\u201cALX\u00a0Oncology\u201d or the \u201cCompany\u201d), (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives, today announced that effective January 21, 2025, the Compensation Committee of the Board of Directors of ALX\u00a0Oncology granted an inducement stock option to purchase a total of 600,000 shares of ALX Oncology\u2019s common stock to Harish Shantharam, the Company\u2019s Chief Financial Officer, in connection with the commencement of his employment. Mr. Shantharam\u2019s inducement stock option is subject to the terms of the ALX\u00a0Oncology Holdings Inc. 2025 Inducement Equity Incentive Plan and related forms of agreements, and were granted as inducements material to Mr. Shantharam to enter into employment with ALX\u00a0Oncology in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock option has an exercise price of $1.65 per share, which is equal to the closing price of a share of ALX Oncology common stock on the grant date, and shall vest as follows: 25% of the shares subject to such inducement stock option shall vest on the one year anniversary of January 21, 2025 and an additional one forty-eighth of the shares subject to such inducement stock option shall vest monthly thereafter, subject to the employee\u2019s continued service. About ALX Oncology ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology . Company Contact: Allison Dillon, Chief Business Officer, ALX Oncology ir@alxoncology.com Media Contact: Audra Friis, Sam Brown, Inc. audrafriis@sambrown.com (917) 519-9577 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-23T00:01:00", "sentiment": {"score": 0.06357126776129007, "confidence": 0.073454849421978, "probabilities": {"positive": 0.073454849421978, "negative": 0.009883581660687923, "neutral": 0.9166615605354309}}, "embedding": [-0.07690685242414474, -0.05209226906299591, -0.00389072485268116, -0.09863043576478958, -0.1080552339553833, 0.009155681356787682, 0.004658248275518417, 0.011021731421351433, 0.09611006081104279, 0.029229700565338135, 0.006608266849070787, 0.02796686440706253, 0.10329893976449966, -0.03876548260450363, -0.07528209686279297, 0.21813654899597168, 0.06314170360565186, -0.016090059652924538, -0.17675574123859406, 0.15565568208694458, 0.02213837206363678, -0.03999483212828636, 0.061880096793174744, 0.022166263312101364, 0.06135614588856697, -0.10541854798793793, -0.0787084698677063, 0.09501706808805466, -0.08711499720811844, -0.0552230179309845, 0.10785497725009918, 0.16047699749469757, -0.009746461175382137, -0.1635003685951233, -0.11969275772571564, -0.0145339360460639, -0.16254273056983948, 0.063963882625103, -0.03941235691308975, 0.07223949581384659, 0.08626729249954224, -0.04165437072515488, -0.05127771943807602, 0.18929584324359894, -0.09662890434265137, -0.1332564651966095, -0.019984599202871323, -0.009436530992388725, 0.07730332016944885, 0.20279470086097717, -0.06955787539482117, -0.07773485779762268, 0.011187929660081863, 0.15153349936008453, -0.1461833417415619, -0.04436955228447914, -0.12422318011522293, 0.053223513066768646, 0.035063304007053375, -0.06025444716215134, -0.00277912151068449, -0.07643614709377289, 0.056255169212818146, 0.14450399577617645, 0.09759809076786041, -0.002813081257045269, -0.028969496488571167, -0.08124838024377823, -0.1428123265504837, -0.05777271091938019, 0.11040018498897552, -0.10618185251951218, 0.021547265350818634, 0.09350523352622986, -0.012577096000313759, 0.1672554612159729, 0.166902557015419, 0.07397502660751343, 0.07019320130348206, -0.10097275674343109, -0.008356509730219841, 0.09211192280054092, 0.12956368923187256, -0.04323222488164902, -0.052528008818626404, -0.08272336423397064, 0.04313402250409126, 0.1253601610660553, 0.05060945451259613, -0.009101453237235546, 0.05968021973967552, -0.00903051346540451, 0.0036198627203702927, -0.06400580704212189, 0.025217773392796516, -0.10346926003694534, -0.04968530684709549, 0.025306928902864456, -0.0693783238530159, 0.03697921335697174, 0.07364550232887268, -0.05698607489466667, -0.13797035813331604, -0.02812613546848297, -0.06380628049373627, -0.04537653550505638, -0.05118287354707718, -0.06617146730422974, -0.046790968626737595, -0.054655686020851135, -0.10284388065338135, 0.005159229971468449, -0.05553000792860985, -0.06069919466972351, -0.11802031099796295, 0.2175244390964508, -0.055018700659275055, -0.12706410884857178, 0.1291809380054474, -0.18926018476486206, -0.019918646663427353, -0.08043935894966125, -0.048831865191459656, -0.014429113827645779, 0.01906362548470497, -0.05087953060865402, -0.11763986945152283, 9.213944226291539e-33, -0.0893189013004303, -0.12513995170593262, 0.033659376204013824, -0.00457305833697319, 0.041629280894994736, -0.09788649529218674, 0.10940838605165482, -0.030357902869582176, -0.23886652290821075, -0.04216689616441727, -0.10840103775262833, 0.12427748739719391, 0.0605919323861599, 0.006883131340146065, 0.003209309186786413, -0.12374281883239746, 0.05149593949317932, 0.033883653581142426, 0.03371347486972809, -0.007857074029743671, 0.05376231297850609, 0.02565174549818039, -0.09567800164222717, 0.059764351695775986, -0.02520839124917984, 0.09622912108898163, -0.001788092777132988, -0.03158295527100563, -0.10037881135940552, 0.028128597885370255, -0.08061226457357407, 0.08856245875358582, -0.06077418848872185, -0.14738419651985168, -0.058275580406188965, 0.0026469938457012177, -0.14326198399066925, -0.058791328221559525, 0.09864276647567749, -0.0500519834458828, 0.01965279132127762, 0.07210823148488998, 0.04072266072034836, -0.1043669581413269, 0.01062131766229868, 0.013837642967700958, -0.0784016102552414, 0.005185090471059084, 0.07125197350978851, 0.08179590106010437, 0.06773854792118073, -0.014101456850767136, 0.026333557441830635, -0.07036957144737244, -0.046228669583797455, -0.011004779487848282, -0.2887657582759857, 0.07042296230792999, 0.0503331795334816, 0.17441998422145844, -0.08326973021030426, 0.037920210510492325, 0.005698301829397678, 0.11927831918001175, -0.21284592151641846, 0.08032797276973724, 0.03621547669172287, -0.18852472305297852, 0.016695132479071617, 0.09755255281925201, -0.09832997620105743, 0.06577573716640472, 0.15283344686031342, -0.021245691925287247, -0.01608152501285076, -0.027971766889095306, 0.0519171878695488, -0.006984579376876354, 0.024951737374067307, 0.13564151525497437, 0.043471187353134155, -0.06300786137580872, -0.08144642412662506, 0.07637155055999756, -0.025253333151340485, -0.033321354538202286, -0.043772801756858826, 0.04668007791042328, -0.1133795827627182, 0.06582757085561752, 0.13562804460525513, -0.0054504526779055595, -0.02451949380338192, 0.12699247896671295, 0.14548087120056152, -1.0366856595950561e-32, 0.026313774287700653, -0.0735025629401207, -0.03459196165204048, -0.14813195168972015, 0.010432075709104538, 0.09775933623313904, 0.07058627903461456, -0.061033137142658234, -0.0062888003885746, -0.01911398023366928, 0.07361572980880737, 0.18010371923446655, -0.016167346388101578, -0.01037801057100296, -0.1940874457359314, -0.05352111905813217, -0.006705452688038349, -0.08448337763547897, -0.03192836046218872, -0.029873177409172058, 0.04763919115066528, 0.25218456983566284, -0.09566708654165268, 0.05630963668227196, 0.00448908656835556, 0.05544115975499153, 0.0539640337228775, 0.17909429967403412, 0.10183605551719666, 0.03563776984810829, -0.13798171281814575, 0.02351786196231842, -0.23236021399497986, 0.0750357061624527, 0.09847335517406464, -0.02635694295167923, 0.10184197127819061, -0.06895890831947327, -0.004253799561411142, 0.031550683081150055, 0.1508113592863083, -0.04370427131652832, 0.02325102873146534, 0.06992197036743164, 0.10974572598934174, 0.056448645889759064, 0.02369018830358982, -0.08007901906967163, 0.18791544437408447, -0.011988385580480099, -0.022047022357583046, 0.09469856321811676, 0.08663547039031982, 0.1029614731669426, 0.03529762476682663, 0.059991881251335144, -0.028057362884283066, -0.11937641352415085, -0.05756022781133652, -0.014371514320373535, 0.02398470789194107, 0.16317510604858398, 0.08784964680671692, -0.07627109438180923, -0.025418978184461594, 0.07201599329710007, -0.061892975121736526, -0.059095047414302826, -0.02436189353466034, -0.004992556758224964, 0.018692176789045334, -0.08728643506765366, -0.0674670934677124, -0.11642228811979294, 0.10843625664710999, 0.10824465751647949, 0.15656234323978424, -0.19960501790046692, -0.16914430260658264, 0.04053027927875519, -0.011180480010807514, -0.04664395749568939, 0.0652834102511406, 0.07066690921783447, 0.06108289957046509, 0.1091911569237709, 0.008159083314239979, 0.02575819566845894, -0.03934900835156441, -0.009410764090716839, -0.07777980715036392, -0.17485162615776062, -0.03992639482021332, 0.029648518189787865, -0.1568250209093094, -1.0044883680393468e-07, -0.00047850608825683594, -0.023760240525007248, 0.07327133417129517, -0.08908776938915253, 0.08349192887544632, 0.02345268800854683, -0.00027653295546770096, 0.004854266531765461, 0.04572644084692001, 0.11442971229553223, 0.10107520967721939, 0.18101906776428223, -0.1252194494009018, -0.0011083399876952171, -0.07733643054962158, 0.033786363899707794, -0.05748641490936279, -0.029558489099144936, 0.0019279709085822105, -0.07584753632545471, -0.10578489303588867, -0.03106633573770523, 0.018580373376607895, 0.014291685074567795, 0.020375709980726242, -0.01031007245182991, 0.0306320209056139, 0.0963195413351059, 0.06897492706775665, 0.08182677626609802, 0.023479195311665535, -0.04781755059957504, 0.007089085876941681, -0.008871624246239662, -0.011687897145748138, -0.06533846259117126, 0.044756483286619186, 0.06297963857650757, 0.11607207357883453, 0.04488901421427727, 0.00773247703909874, 0.05559235066175461, 0.02996138110756874, 0.003252776339650154, -0.06145370006561279, 0.04848210886120796, -0.14335057139396667, -0.1286875158548355, 0.03069468028843403, -0.16920050978660583, 0.06914495676755905, -0.05697662755846977, -0.04854371398687363, 0.011385755613446236, -0.0486445277929306, 0.05484744906425476, -0.0820336639881134, -0.10898049175739288, 0.04860581457614899, -0.044402021914720535, 0.05832790583372116, -0.14408078789710999, 0.06708525866270065, 0.021389562636613846], "changes": {"1wk": -18.888884620901866}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology Announces Further Additions to Leadership Team and Board of Directors, Appointing Harish Shantharam as Chief Financial Officer and Adding Barbara Klencke and Chris Takimoto to Board of Directors ALX Oncology Wed, Jan 22, 2025, 4:00 PM 6 min read In This Article: ALXO ALX Oncology Mr. Shantharam is a proven biotech industry executive with over two decades of senior leadership experience in finance, commercial and corporate operations Dr. Klencke is a seasoned clinical leader in oncology drug development with more than 20 years of industry experience Dr. Takimoto brings a distinguished track record in oncology and drug development with 17 years of industry experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d or the \u201cCompany\u201d) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives, today announced the appointment of Harish Shantharam, CFA, as Chief Financial Officer (CFO). In addition, the company appointed Barbara Klencke, M.D., and Chris H. Takimoto, M.D., Ph.D., FACP, to its Board of Directors. These appointments follow the recent additions to the ALX Oncology executive team of Alan Sandler, M.D., as Chief Medical Officer, and Allison Dillon, Ph.D., as Chief Business Officer. \u201cWe are excited to welcome Harish, Barbara and Chris to the ALX Oncology team,\u201d said Jason Lettmann, Chief Executive Officer at ALX Oncology. \u201cTheir diverse range of experience adds deep financial, clinical and business development leadership to our team as we advance our lead candidate evorpacept into late-stage clinical trials in 2025. Harish brings a proven track record of leading finance functions with an emphasis on operational excellence to deliver results through pivotal growth periods, building high performing teams and scaling organizations, which will be invaluable as we embark on a transformational year for ALX. Barbara and Chris are globally recognized and well-respected oncology leaders with demonstrated business acumen who share our dedication to advancing and delivering clinically meaningful immuno-oncology innovation.\u201d \u201cI look forward to working with Barbara and Chris on the Board of Directors,\u201d said Corey Goodman, Ph.D., Chairman of ALX Oncology. \u201cTheir expertise in cancer research and in the development of innovative oncology therapies across all stages of R&D \u2013 from discovery to regulatory approval and commercialization \u2013 make them exceptional additions and assets to the ALX Oncology Board.\u201d Harish Shantharam, CFA Mr. Shantharam has over 20 years of experience in financial and commercial functions at a broad range of biotech and biopharmaceutical companies at various stages of growth and market capitalization. His expertise spans finance strategy and operations, commercialization, capital markets engagement and business development. Most recently, he served as Chief Financial Officer at CymaBay Therapeutics, where he helped guide the company in its transition towards late-stage development and commercial readiness and through its $4.3 billion acquisition by Gilead Sciences. Earlier in his career, he served in roles of increasing responsibility and scope at Gilead Sciences, including as Vice President and Head of Global Commercial Finance, when he led the financial operations supporting a $20-$30 billion dollar revenue business globally. While at Gilead, he also led business development activities for finance for several strategic acquisitions and supported numerous major new product launches in financial and commercial operations capacities. Prior to Gilead, Mr. Shantharam served in various roles of increasing responsibility driving forecasting, commercial analytics and business development at Amgen. Mr. Shantharam holds an MBA in finance from UCLA Anderson School of Management and a graduate degree in Industrial Engineering from the University of Texas at Arlington. He is also a CFA charter holder. Story Continues Barbara Klencke, M.D. Dr. Klencke has over 30 years of experience in patient care, academic and scientific research and clinical drug development in hematology and oncology. She has deep R&D expertise and has made significant contributions to the development, approval and commercialization of numerous oncology products through various executive leadership roles at a range of small, mid-sized and large biotech companies including Sierra Oncology (acquired by GlaxoSmithKline for $1.9 billion), Onyx Pharmaceuticals (acquired by Amgen for $10.4 billion) and Genentech, a member of the Roche Group. Prior to entering the biotechnology industry, Dr. Klencke served as an Assistant Clinical Professor of Medicine, Division of Hematology and Oncology, at the University of California, San Francisco, where she previously completed her training in hematology, oncology and internal medicine. She holds a Bachelor of Science degree from Indiana University and an M.D. from the University of California, Davis. In addition to ALX Oncology, Dr. Klencke is an independent board director of Xencor, TScan Therapeutics and Immune-Onc Therapeutics. Chris H. Takimoto, M.D., Ph.D., FACP Dr. Takimoto has over 30 years of experience in oncology and pharmacology through a distinguished career across academia, industry and public service. As a cancer researcher and drug developer, he has spearheaded the clinical development of numerous oncology products. Currently, Dr. Takimoto serves as Global Chief Medical Officer at the START Center for Cancer Research. Previously, he served as Chief Medical Officer at IGM Biosciences and Forty Seven through its acquisition by Gilead for $4.9 billion, and as Senior Vice President of Oncology at Gilead Sciences. Prior to that, he held roles of increasing responsibility in oncology drug development at Janssen/Johnson & Johnson. Dr. Takimoto was also an independent board director for Tizona Therapeutics. He has held academic positions at the University of Texas Health Science Center at San Antonio, the National Cancer Institute and the Uniformed Services University of the Health Sciences, and he has served as a Commissioned Officer in the U.S. Public Health Service. Dr. Takimoto completed his internship and residency in internal medicine at the University of California, San Francisco, and a fellowship in oncology at the National Cancer Institute. He received a Bachelor of Science degree in chemistry from Stanford University, a Ph.D. in pharmacology from Yale University and an M.D. from Yale University School of Medicine. About ALX Oncology ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology . Cautionary note regarding forward-looking statements This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-looking statements include statements regarding future results of operations and financial position, business strategy, product candidates, planned preclinical studies and clinical trials, results of clinical trials, research and development costs, regulatory approvals, timing and likelihood of success, plans and objects of management for future operations, as well as statements regarding industry trends. Such forward-looking statements are based on ALX Oncology\u2019s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause ALX Oncology\u2019s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These and other risks are described more fully in ALX Oncology\u2019s filings with the Securities and Exchange Commission (SEC), including ALX Oncology\u2019s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other documents ALX Oncology files with the SEC from time to time. Except to the extent required by law, ALX Oncology undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Company Contact: Allison Dillon, Chief Business Officer, ALX Oncology ir@alxoncology.com Media Contact: Audra Friis, Sam Brown, Inc. audrafriis@sambrown.com (917) 519-9577 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-22T16:00:00", "sentiment": {"score": 0.6455995570868254, "confidence": 0.6555636525154114, "probabilities": {"positive": 0.6555636525154114, "negative": 0.009964095428586006, "neutral": 0.3344722390174866}}, "embedding": [-0.06418897211551666, -0.12585870921611786, -0.005086708813905716, -0.09052211046218872, -0.07874934375286102, -0.03146861493587494, -0.015587499365210533, 0.045308616012334824, 0.11502154171466827, 0.0197595302015543, -0.14550966024398804, 0.02241831086575985, 0.02750132419168949, -0.05892251431941986, -0.17173735797405243, 0.12325996160507202, 0.05959378927946091, -0.02960505522787571, -0.1585153043270111, 0.11469174176454544, -0.03512757271528244, -0.08467906713485718, 0.08538524806499481, 0.007180267479270697, 0.009208234027028084, 0.0015994585119187832, -0.09672986716032028, -0.007700733374804258, -0.19674403965473175, -0.11486829817295074, 0.10402417182922363, 0.1569419503211975, 0.027457889169454575, -0.10122997313737869, -0.027136126533150673, 0.08157826960086823, -0.07002924382686615, 0.11797352880239487, -0.04507699981331825, -0.03205200657248497, 0.056647464632987976, -0.06776835769414902, -0.07974240183830261, 0.15914392471313477, -0.05677599832415581, -0.21522390842437744, 0.02466510981321335, -0.08185981214046478, 0.06465867906808853, 0.17224562168121338, -0.16173779964447021, -0.1192702129483223, -0.004254315979778767, 0.15145960450172424, -0.08413968980312347, 0.030600178986787796, -0.040259502828121185, -0.043784502893686295, 0.027417495846748352, -0.08456277847290039, -0.007050810381770134, -0.0489007830619812, 0.0676061138510704, 0.1388048231601715, 0.10214592516422272, 0.0036189276725053787, -0.060998596251010895, -0.04057285934686661, -0.1533217430114746, -0.06355185061693192, 0.10933014005422592, -0.10727281123399734, 0.03475769981741905, 0.14088952541351318, 0.08062878251075745, 0.13326957821846008, 0.21846500039100647, 0.0988098755478859, 0.14407406747341156, -0.059230975806713104, 0.0939718633890152, 0.0637507438659668, 0.15277114510536194, -0.005756955593824387, -0.08002816140651703, -0.020974325016140938, 0.03164315223693848, 0.06826501339673996, 0.030186697840690613, -0.010397729463875294, 0.03289397433400154, 0.0978410542011261, 0.05375939980149269, -0.02214907296001911, -0.010555952787399292, -0.05479937791824341, -0.006115781608968973, 0.06828954815864563, -0.03172196075320244, 0.05817120149731636, 0.033577192574739456, 0.026546908542513847, -0.11069663614034653, -0.05892430990934372, -0.09326885640621185, -0.048312313854694366, -0.003478365484625101, -0.07185984402894974, -0.05078507587313652, -0.03698471561074257, -0.0369037464261055, 0.0797286331653595, -0.08593378216028214, 0.015764081850647926, -0.08974456042051315, 0.1085936576128006, -0.09288661181926727, -0.0691617876291275, 0.07110829651355743, -0.12492527812719345, 0.012278062291443348, 0.0002728644758462906, -0.05139406770467758, 0.009928828105330467, 0.052334025502204895, 0.032933272421360016, -0.13364820182323456, 9.844496293803907e-33, -0.03902088478207588, -0.02687550149857998, 0.06619060039520264, -0.008074422366917133, -0.0006737764924764633, -0.02272026613354683, 0.048505280166864395, -0.06151895970106125, -0.2714090943336487, -0.10766321420669556, -0.1266125589609146, 0.0819537341594696, 0.04292414337396622, -0.06339255720376968, -0.07061156630516052, -0.1422116756439209, -0.019173260778188705, -0.013556210324168205, -0.0120204146951437, -0.03180183097720146, -0.01821538433432579, -0.03176165744662285, -0.11088007688522339, 0.057080067694187164, -0.00027507368940860033, 0.1039978638291359, 0.025575829669833183, 0.009333568625152111, -0.011159757152199745, 0.05337841436266899, -0.1367482841014862, 0.04831797629594803, -0.01282590627670288, -0.06672687828540802, -0.09461797773838043, -0.025132331997156143, -0.1513131856918335, -0.06928938627243042, 0.05126701295375824, 0.037762146443128586, -0.08710871636867523, 0.09723125398159027, -0.02670658938586712, -0.042370669543743134, -0.046488381922245026, -0.02937152609229088, -0.04513775184750557, 0.005789753049612045, 0.1343526840209961, 0.006688716821372509, -0.05520990490913391, -0.024932242929935455, 0.09906628727912903, -0.02785671129822731, 0.04235074296593666, -0.005116695072501898, -0.16953682899475098, -0.011343949474394321, 0.052653390914201736, 0.10117436945438385, -0.03689888119697571, 0.052662067115306854, -0.09450652450323105, 0.12842467427253723, -0.15209528803825378, 0.0173244196921587, 0.05497186630964279, -0.06552129238843918, 0.04186069965362549, 0.08299608528614044, -0.1025717705488205, 0.005516492296010256, 0.20652154088020325, 0.07718851417303085, -0.05664527788758278, 0.016979310661554337, 0.07385706156492233, -0.0018374891951680183, -0.04406984895467758, 0.11282773315906525, 0.0891028493642807, -0.03225908428430557, -0.05868382006883621, 0.10449700057506561, -0.030224325135350227, -0.08274751901626587, -0.050606176257133484, -0.0026562511920928955, -0.14545391499996185, 0.05505821108818054, 0.03281455114483833, -0.059399645775556564, 0.009761170484125614, 0.09933467209339142, 0.02219819650053978, -1.1336147197119542e-32, 0.0714111328125, -0.0396052747964859, 0.02918659895658493, -0.15361157059669495, 0.042808614671230316, 0.06924648582935333, 0.050574611872434616, -0.09972188621759415, 0.0376899391412735, -0.0905829519033432, 0.14860808849334717, 0.1583957076072693, -0.06956244260072708, -0.03454577922821045, -0.13074493408203125, -0.009796064347028732, 0.05166143551468849, -0.15363770723342896, -0.09099922329187393, -0.1438816487789154, 0.08738209307193756, 0.25391143560409546, -0.17433732748031616, 0.07131452858448029, -0.10246003419160843, 0.10457251965999603, 0.11445342004299164, 0.13531850278377533, 0.02275174856185913, -0.023133695125579834, -0.09654548764228821, 0.003762447740882635, -0.16422580182552338, 0.024629250168800354, 0.05475368723273277, 0.07814254611730576, -0.03468940779566765, -0.12213296443223953, -0.03723781555891037, 0.050699591636657715, 0.17753377556800842, 0.017978008836507797, -0.028400301933288574, -0.010400529950857162, 0.09708670526742935, 0.07715512067079544, -0.043260358273983, -0.04841485247015953, 0.15492558479309082, 0.008503999561071396, -0.083953857421875, 0.08242204785346985, -0.064088836312294, 0.007282835431396961, -0.010039569810032845, 0.09905704110860825, 0.03585263341665268, -0.037682101130485535, -0.02430235594511032, -0.031012792140245438, 0.01371045783162117, 0.14103318750858307, 0.1521894931793213, -0.07748819887638092, -0.02403540164232254, 0.12152732908725739, 0.004068868234753609, -0.0510428287088871, -0.0874541848897934, 0.05380804091691971, -0.03611592948436737, -0.026437314227223396, -0.17187091708183289, -0.06467118859291077, 0.006461551412940025, 0.06519022583961487, -0.034720778465270996, -0.1410776674747467, -0.16054421663284302, 0.07759551703929901, 0.025794396176934242, -0.03190618008375168, 0.09110258519649506, 0.07855035364627838, 0.10752075910568237, 0.13055837154388428, 0.0024353377521038055, -0.03492546081542969, -0.01698533445596695, 0.000273390905931592, -0.005924309138208628, -0.22401297092437744, -0.09324301779270172, 0.06708305329084396, -0.06882435083389282, -1.0083499546453822e-07, 0.05495297163724899, -0.05011142045259476, -0.025257239118218422, -0.08914297074079514, 0.08140036463737488, 0.037253282964229584, -0.0932178646326065, 0.00274864723905921, 0.09072437882423401, 0.13890613615512848, 0.11827927827835083, 0.1381743848323822, -0.12160156667232513, 0.018660403788089752, 0.07102997601032257, 0.08513650298118591, -0.11546137928962708, 0.03403851389884949, -0.03567823767662048, -0.09685049206018448, -0.13630716502666473, 0.0930933952331543, 0.023389682173728943, 0.05592590570449829, 0.04515232518315315, -0.049921926110982895, -0.05809187889099121, 0.06348694115877151, 0.09586930274963379, 0.09855106472969055, -0.007118000648915768, 0.027619093656539917, -0.009429672732949257, -0.03363875299692154, -0.0068468619138002396, -0.08442127704620361, -0.0021014707162976265, 0.02884816750884056, 0.11918048560619354, 0.1461305022239685, 0.011333182454109192, 0.09197857230901718, -0.019701197743415833, 0.08039794862270355, -0.10466969758272171, -0.008409243077039719, -0.08405643701553345, 0.0004504916723817587, 0.05206974968314171, -0.16565558314323425, 0.011577236466109753, -0.0028091324493288994, -0.050998132675886154, 0.023300418630242348, -0.07031074911355972, 0.1203041821718216, -0.09998589754104614, -0.06765791028738022, -0.007790639065206051, -0.05155767500400543, 0.033117350190877914, -0.18566468358039856, 0.14032338559627533, 0.03106001392006874], "changes": {"1wk": -14.999999337726152}}, {"text": "LIVE The latest news and updates on Trump's tariffs PREMIUM Sector Update: Health Care Stocks Softer Late Afternoon MT Newswires Wed, Jan 22, 2025, 11:52 PM 1 min read In This Article: ABT CLSD Health care stocks eased late Wednesday afternoon, with the NYSE Health Care Index and the Health Ca PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-22T23:52:05", "sentiment": {"score": 0.05430830083787441, "confidence": 0.07524394989013672, "probabilities": {"positive": 0.07524394989013672, "negative": 0.020935649052262306, "neutral": 0.9038203358650208}}, "embedding": [-0.09413090348243713, -0.08335940539836884, 0.1397809535264969, 0.06448130309581757, 0.2077353149652481, -0.052083536982536316, -0.012908181175589561, -0.009911991655826569, -0.17334525287151337, -0.031839605420827866, -0.04816234111785889, 0.1257081776857376, -0.13364183902740479, -0.03781328350305557, 0.020468544214963913, 0.06972812116146088, 0.07122115045785904, 0.04037830978631973, -0.1204388365149498, 0.18468773365020752, -0.09919305145740509, -0.0015078982105478644, 0.07883145660161972, 0.03453204408288002, 0.029735635966062546, 0.12166242301464081, -0.032601360231637955, -0.1847316473722458, -0.011989081278443336, -0.03392965719103813, -0.08256550133228302, -0.10103271901607513, -0.01822078786790371, 0.015265127643942833, -0.05266832932829857, -0.05714144557714462, 0.09541629999876022, 0.08996941894292831, 0.10135328024625778, 0.01420839224010706, 0.16819486021995544, -0.16907089948654175, -0.08475811779499054, 0.060718197375535965, -0.008778088726103306, -0.02314881794154644, -0.061863191425800323, -0.007648062892258167, 0.09510235488414764, 0.11029733717441559, -0.061955004930496216, -0.029028568416833878, 0.04605473577976227, -0.018800823017954826, 0.052547942847013474, -0.06504001468420029, -0.13258859515190125, -0.04346511512994766, 0.02356046624481678, 0.02301245927810669, -0.06199459731578827, -0.12280288338661194, 0.058236707001924515, 0.15894831717014313, 0.014072469435632229, 0.01621180772781372, -0.01792997494339943, 0.055681269615888596, -0.08179446309804916, -0.20519989728927612, 0.022754434496164322, 0.04910840094089508, 0.0033876181114465, -0.059184398502111435, 0.07948249578475952, 0.02876746468245983, 0.19679582118988037, 0.003227806417271495, 0.10589472204446793, -0.12521135807037354, 0.007924479432404041, -0.053439006209373474, 0.08013409376144409, -0.005249020177870989, -0.0486210435628891, -0.10102001577615738, -0.031988974660634995, -0.08745788782835007, -0.051695410162210464, -0.16710370779037476, 0.18912701308727264, -0.03179176524281502, 0.006780453957617283, 0.0487738698720932, -0.0786469578742981, 0.04519771784543991, -0.0935080349445343, 0.021602395921945572, -0.27577218413352966, 0.08574147522449493, 0.031429801136255264, 0.051107440143823624, -0.022280504927039146, 0.0702371597290039, -0.10277365148067474, -0.15890257060527802, -0.11417441815137863, 0.10195805877447128, 0.004941293969750404, 0.17001062631607056, 0.07552684098482132, 0.08755528181791306, -0.028195368126034737, -0.15773525834083557, -0.18244320154190063, 0.017576362937688828, -0.08029744774103165, -0.15980999171733856, 0.06848151236772537, -0.008972647599875927, 0.07918497174978256, 0.12848283350467682, -0.2787301242351532, -0.01712411642074585, 0.005785100162029266, 0.09537816047668457, 0.0056879036128520966, 9.207448150635308e-33, 0.01656421832740307, 0.06916799396276474, 0.04387678951025009, -0.058511875569820404, -0.03816094622015953, 0.04883069917559624, 0.04284045100212097, -0.2318989336490631, -0.02581886574625969, -0.11216829717159271, -0.09046684950590134, 0.27996382117271423, -0.051759522408246994, 0.01983874849975109, -0.16872663795948029, -0.3147830665111542, -0.13349784910678864, 0.0513475239276886, 0.1428624987602234, 0.0931977704167366, 0.06866444647312164, -0.0715605691075325, -0.029543764889240265, -0.0550873801112175, -0.002426091581583023, 0.042910076677799225, 0.13579061627388, -0.10184136033058167, 0.05804997682571411, 0.09286317229270935, -0.15487636625766754, 0.2003251016139984, -0.027174966409802437, -0.04846108332276344, -0.004078790545463562, 0.09328525513410568, -0.10598576068878174, 0.004772921092808247, -0.10136836022138596, -0.22272667288780212, -0.03848331421613693, 0.023387150838971138, -0.08678659051656723, 0.047411784529685974, 0.1034129187464714, 0.01833963952958584, 0.025878092274069786, -0.029294347390532494, 0.13835643231868744, -0.14453020691871643, -0.11222037672996521, 0.1206497997045517, -0.13610374927520752, -0.1505565494298935, -0.007743372581899166, 0.009063287638127804, -0.01032853964716196, -0.22174072265625, 0.008265042677521706, -0.000710581021849066, 0.270661324262619, 0.026133956387639046, 0.029567357152700424, -0.002720657968893647, -0.16594697535037994, 0.10051819682121277, -0.2205413281917572, 0.03669947385787964, -0.13984884321689606, 0.08871157467365265, 0.1661493331193924, -0.026655593886971474, 0.06031183525919914, -0.004632891621440649, -0.13934655487537384, 0.0800488218665123, -0.05122069641947746, 0.017747003585100174, 0.06025167182087898, 0.02699637971818447, 0.11173346638679504, -0.08053355664014816, 0.24580751359462738, 0.08331241458654404, 0.13173320889472961, 0.07831660658121109, -0.07084345817565918, 0.08468551933765411, 0.05092728137969971, -0.015090035274624825, -0.2258063703775406, 0.027909521013498306, 0.09663406759500504, 0.07944325357675552, -0.11747700721025467, -1.3381411858634318e-32, -0.07398994266986847, 0.005270953755825758, -0.010325438342988491, -0.042128004133701324, -0.0526428297162056, -0.047344401478767395, 0.008285736665129662, 0.18853820860385895, 0.1513475477695465, 0.14241819083690643, 0.020906761288642883, 0.02135859988629818, -0.1336330622434616, 0.1326979100704193, 0.06791479140520096, 0.047921303659677505, 0.0008096482488326728, -0.09014170616865158, -0.13356831669807434, 0.16165323555469513, 0.020654616877436638, 0.12559616565704346, -0.1691143810749054, 0.40005651116371155, 0.016256114467978477, -0.02295246534049511, 0.07487910985946655, 0.12739090621471405, 0.0684133768081665, -0.15903666615486145, -0.22607558965682983, -0.01593901216983795, -0.09495347738265991, 0.04717296361923218, -0.09196287393569946, -0.010442694649100304, 0.14515462517738342, 5.59140789846424e-05, -0.03431160748004913, -0.10055453330278397, 0.13616390526294708, -0.14750628173351288, -0.09911882877349854, 0.044763900339603424, 0.12231674045324326, 0.10671139508485794, -0.10434772074222565, 0.03317800536751747, -0.09817849099636078, 0.025251135230064392, -0.0821002870798111, 0.12822766602039337, -0.05899214372038841, 0.1675599068403244, -0.15676283836364746, 0.0695936307311058, -0.09149385243654251, -0.04607222601771355, -0.13707681000232697, -0.047845494002103806, -0.027404921129345894, 0.22300846874713898, -0.11740293353796005, -0.08517200499773026, -0.06437728554010391, -0.03029313124716282, -0.001585250603966415, -0.23382416367530823, 0.09468581527471542, -0.04491227865219116, -0.04352632537484169, -0.1472620815038681, -0.1651611328125, -0.30282267928123474, 0.10564779490232468, 0.13641948997974396, 0.022975798696279526, -0.05657033249735832, -0.03304694965481758, 0.19974830746650696, 0.16702581942081451, -0.05944187566637993, 0.061363402754068375, -0.059641625732183456, -0.02218700759112835, 0.11823025345802307, 0.12083262205123901, -0.13379795849323273, -0.14538820087909698, 0.10694245994091034, -0.25054576992988586, -0.15381930768489838, -0.16654768586158752, 0.11002553999423981, -0.0883769690990448, -9.963089553366444e-08, 0.1392393559217453, -0.07603783160448074, -0.036809250712394714, 0.032212842255830765, -0.020732058212161064, -0.008875583298504353, -0.17194081842899323, -0.09657660126686096, -0.03133600950241089, 0.19053199887275696, 0.050215721130371094, 0.09789086133241653, -0.11296616494655609, 0.028012078255414963, -0.010369054041802883, 0.05520501360297203, -0.07640282064676285, 0.14623528718948364, -0.004340853542089462, -0.10316139459609985, -0.005096049048006535, 0.1698526293039322, 0.21605241298675537, 0.07614298909902573, 0.11776226758956909, 0.10835278034210205, -0.13724951446056366, -0.014628784731030464, 0.16195398569107056, 0.057389672845602036, -0.09696238487958908, 0.002593965968117118, -0.10025462508201599, -0.035619817674160004, 0.06291691958904266, 0.018692662939429283, 0.08932604640722275, 0.013449694029986858, 0.15429678559303284, 0.11329109966754913, 0.10515066981315613, -0.013403093442320824, 0.06241900473833084, 0.028397008776664734, -0.00876221340149641, -0.05460994318127632, -0.143114373087883, -0.05654110759496689, 0.20344598591327667, -0.0214880108833313, -0.012081214226782322, -0.1978137195110321, 0.15326231718063354, -0.09356362372636795, 0.08077021688222885, 0.09858407825231552, -0.09071510285139084, -0.162653848528862, -0.14872512221336365, 0.16957801580429077, 0.14903698861598969, -0.22136184573173523, 0.08571487665176392, 0.2081228345632553], "changes": {"1wk": -18.888884620901866}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI ALX Oncology Wed, Jan 22, 2025, 1:00 AM 2 min read In This Article: ALXO ALX Oncology Webcast on January 23 at 1:00 p.m. PT/4:00 p.m. ET will review updated data from trial evaluating CD47-blocker evorpacept in HER2-positive gastric cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d or the \u201cCompany\u201d) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives, today announced that the company will host a virtual event on Thursday, January 23, at 1:00 p.m. PT/4:00 p.m. ET to discuss updated data from the ASPEN-06 Phase 2 clinical trial evaluating the company\u2019s investigational CD47-blocker evorpacept in patients with previously treated HER2-positive advanced gastric cancer (GC) or gastroesophageal junction (GEJ) cancer. The ASPEN-06 data will be featured in an oral presentation (Abstract #332) at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) earlier the same day. 2025 ASCO GI Presentation Details Title: Final analysis of the randomized phase 2 part of the ASPEN-06 study: A phase 2/3 study of evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with HER2-overexpressing gastric/gastroesophageal cancer (GC). Abstract Number: 332 Presenter: Kohei\u00a0Shitara, M.D., Director of the Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa in Japan Presentation Date and Time: Thursday, January 23, 9:15 a.m. \u2013 10:00 a.m. PT Session Information: Rapid Oral Abstract Session A: Cancers of the Esophagus and Stomach Location: Level 2 Ballroom Company Conference Call and Webcast Information During the virtual company conference call and webcast event for investors, ALX company leadership will review the updated ASPEN-06 data. The event will be webcast live and a replay will be available after the call by visiting the \u201cInvestors\u201d section of ALX Oncology\u2019s website and selecting \u201cEvents and Presentations.\u201d Date & Time: Thursday, January 23, 1:00 p.m. PT/4:00 p.m. ET Webcast Access : https://edge.media-server.com/mmc/p/ipy66o44 About ALX Oncology ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ALX Oncology . Story Continues CONTACT: Company Contact: Caitlyn Doherty, Manager, Corporate Communications, ALX Oncology cdoherty@alxoncology.com (650) 466-7125 Media Contact: Audra Friis, Sam Brown, Inc. audrafriis@sambrown.com (917) 519-9577 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-22T01:00:00", "sentiment": {"score": 0.021210215985774994, "confidence": 0.03911871463060379, "probabilities": {"positive": 0.03911871463060379, "negative": 0.017908498644828796, "neutral": 0.9429728388786316}}, "embedding": [0.008482937701046467, -0.07610708475112915, -0.059008873999118805, -0.036886755377054214, 0.003190387971699238, -0.11398881673812866, -0.029107999056577682, 0.09939485788345337, 0.14259833097457886, 0.01846146024763584, -0.023062996566295624, 0.04778088629245758, 0.04630125313997269, -0.03321605548262596, -0.06606236845254898, 0.11539511382579803, 0.17282094061374664, -0.03329875320196152, -0.11519598960876465, 0.1369474232196808, 0.08931795507669449, -0.051163434982299805, 0.1315954327583313, 0.06448598951101303, -0.060208532959222794, -0.0792422667145729, -0.15427044034004211, 0.05027926713228226, -0.11417288333177567, -0.07251033186912537, 0.031415387988090515, 0.04583049193024635, 0.021056726574897766, 0.02546079084277153, 0.1338091492652893, -0.06351566314697266, -0.05748314410448074, 0.07651107013225555, -0.06940700113773346, 0.03540574386715889, -0.004340475425124168, -0.08760052919387817, -0.031010448932647705, 0.04431334510445595, -0.06910499185323715, -0.13842885196208954, -0.12993955612182617, 0.05052715539932251, -0.006722471676766872, 0.2677319645881653, -0.011099260300397873, -0.049411773681640625, -0.05267423391342163, 0.11366021633148193, -0.034518834203481674, -0.003154890611767769, -0.10166023671627045, 0.010498715564608574, 0.06672992557287216, -0.030469564720988274, 0.019602738320827484, -0.014513793401420116, 0.013392445631325245, 0.14133886992931366, 0.022611403837800026, -0.055702731013298035, -0.026257526129484177, -0.03447893634438515, -0.06847579777240753, -0.066254161298275, -0.03078433685004711, -0.06905190646648407, 0.0408138744533062, 0.10398904979228973, 0.05650690570473671, 0.055831585079431534, 0.11298917233943939, 0.050811685621738434, 0.0700674057006836, -0.01704064942896366, 0.10052788257598877, 0.12811213731765747, 0.15721464157104492, -0.023086771368980408, -0.09361528605222702, 0.027610350400209427, 0.03336877375841141, 0.21826839447021484, 0.033528439700603485, -0.024010226130485535, 0.02332242764532566, 0.017062745988368988, 0.02819882519543171, 0.02405628189444542, 0.09712915867567062, -0.11624427139759064, 0.01392412930727005, 0.0033352833706885576, 0.08956409990787506, -0.012467627413570881, -0.004618683829903603, -0.05351351201534271, -0.025483598932623863, -0.04849224537611008, -0.010152269154787064, 0.002317439764738083, 0.018051527440547943, 0.04727865010499954, -0.02058274671435356, -0.07357164472341537, 0.03283757343888283, 0.032064054161310196, 0.0862373411655426, -0.09543314576148987, 0.044229812920093536, 0.21251347661018372, -0.07434387505054474, -0.025593161582946777, 0.13613472878932953, -0.08514412492513657, -0.01778496615588665, -0.08858290314674377, 0.08541890978813171, 0.007023397367447615, 0.05785315856337547, 0.06301180273294449, -0.06179014593362808, 1.2631212833307472e-32, -0.10825027525424957, -0.0774911418557167, 0.05546009913086891, -0.0190731268376112, 0.07382141053676605, 0.013088355772197247, 0.042183153331279755, -0.05738707631826401, -0.09179480373859406, -0.010977573692798615, -0.1084582656621933, -0.08356792479753494, 0.1341058909893036, 0.020048988983035088, -0.1037701964378357, -0.02368941530585289, -0.021775998175144196, 0.05413025617599487, -0.15543800592422485, -0.024828387424349785, 0.01887732371687889, -0.05787280946969986, -0.019395774230360985, 0.016627173870801926, -0.027353517711162567, 0.15322859585285187, -0.08726327121257782, -0.012630622833967209, -0.008496757596731186, -0.006626736372709274, -0.15477412939071655, 0.050759606063365936, 0.005011911503970623, 0.007155700586736202, -0.03844526410102844, 0.04936297982931137, -0.041740790009498596, -0.11565126478672028, 0.03862231597304344, 0.004875636659562588, -0.07818188518285751, 0.06251872330904007, -0.05541522055864334, -0.059203941375017166, 0.03288187459111214, -0.1637726128101349, -0.010608047246932983, 0.0017587235197424889, 0.09297890961170197, 0.04401850327849388, 0.04794776067137718, -0.00442161550745368, -0.030813045799732208, -0.04382700473070145, -0.07396324723958969, 0.029386404901742935, -0.14030855894088745, 0.007039796561002731, 0.09598090499639511, 0.1505746841430664, 0.0015958966687321663, 0.05821600928902626, -0.06606920063495636, 0.013593727722764015, -0.0667089968919754, 0.026146458461880684, -0.026850247755646706, -0.19893351197242737, -0.004591633565723896, 0.08435836434364319, -0.04913339018821716, -0.012832584790885448, 0.18107226490974426, 0.0429307259619236, 0.10353106260299683, -0.07022423297166824, 0.0699644535779953, 0.12002961337566376, -0.0165531225502491, 0.11587685346603394, -0.021748125553131104, -0.07053040713071823, -0.08400388807058334, 0.060486987233161926, -0.16286443173885345, -0.10134017467498779, -0.04096650332212448, 0.005069052800536156, -0.13645127415657043, 0.12472983449697495, 0.07794912159442902, -0.029541637748479843, -0.0031767822802066803, 0.10992211848497391, 0.040995754301548004, -1.394558449483972e-32, -0.012265893630683422, 0.012428993359208107, 0.007670162245631218, -0.08248519897460938, 0.06871981918811798, 0.026752259582281113, 0.04340466111898422, -0.10677800327539444, 0.04063885658979416, -0.1595814973115921, 0.12567928433418274, 0.18561407923698425, -0.02107311598956585, 0.006151062436401844, -0.020872902125120163, 0.030070118606090546, -0.009561372920870781, -0.07757265865802765, -0.12467928230762482, 0.051551703363657, 0.04407525435090065, 0.12398229539394379, -0.11237423121929169, -0.015715856105089188, -0.09747185558080673, 0.046431511640548706, 0.16682615876197815, 0.04121273010969162, 0.11020034551620483, -0.09519776701927185, -0.06248810887336731, 0.13305069506168365, -0.2099425345659256, 0.032619066536426544, 0.02611077018082142, -0.030666682869195938, -0.02259513922035694, -0.13395625352859497, -0.08495639264583588, -0.1674698442220688, 0.08552687615156174, 0.05146127939224243, -0.08385379612445831, 0.010378637351095676, 0.09818059206008911, 0.18486419320106506, 0.08809583634138107, -0.01740681752562523, 0.17079557478427887, -0.026863571256399155, -0.11711439490318298, 0.043129004538059235, -0.0460662916302681, 0.03340192139148712, 0.06917726993560791, 0.04974929243326187, -0.028027726337313652, -0.15617482364177704, -0.10188236087560654, -0.00048156268894672394, 0.012102394364774227, 0.11305859684944153, 0.09152381122112274, -0.017114657908678055, 0.0790562853217125, 0.13441216945648193, 0.09539330005645752, -0.02569846250116825, 0.01523514837026596, 0.01929231360554695, -0.07234131544828415, -0.011335821822285652, -0.14588214457035065, -0.07921481132507324, 0.031697504222393036, 0.08109389245510101, 0.110716313123703, -0.07277990877628326, -0.06982170045375824, -0.07377560436725616, -0.09049920737743378, -0.0387459397315979, 0.0185752771794796, -0.0435265451669693, 0.11700910329818726, 0.2003690004348755, -0.1001347005367279, 0.0038383929058909416, -0.1015215516090393, 0.03180558234453201, -0.08924945443868637, -0.11881855130195618, -0.07030410319566727, 0.014940096996724606, -0.033800821751356125, -9.992801608404989e-08, 0.05726192891597748, 0.013790586963295937, 0.04462994635105133, -0.1704900562763214, 0.00539031159132719, 0.05518938601016998, -0.04675500839948654, 0.05383527651429176, -0.02499847114086151, 0.09607259929180145, 0.08880461752414703, 0.13324955105781555, -0.044818662106990814, -0.10206920653581619, -0.028698164969682693, 0.0326802097260952, -0.07415343821048737, -0.005487365648150444, -0.037720225751399994, -0.0753549337387085, -0.10335928946733475, -0.07401211559772491, 0.06604259461164474, -0.0687732994556427, -0.011605816893279552, 0.004567841999232769, 0.06726839393377304, 0.1972290277481079, 0.049790702760219574, -0.07413262128829956, -0.03689860180020332, 0.0013783164322376251, -0.10574917495250702, -0.019706541672348976, 0.03137732297182083, -0.11769436299800873, -0.02613680809736252, 0.046723075211048126, 0.13547366857528687, 0.15553006529808044, 0.06413669884204865, -0.001623927615582943, 0.04008198156952858, -0.02744932658970356, -0.04767794907093048, 0.03349856287240982, -0.09840760380029678, -0.09048694372177124, 0.02409260720014572, -0.09388264268636703, -0.0627986341714859, -0.14067387580871582, -0.06724074482917786, -0.003503672778606415, -0.018265416845679283, 0.10618838667869568, -0.0466768704354763, -0.09680940210819244, 0.054512932896614075, -0.05735533684492111, 0.03794025629758835, -0.1445450335741043, -0.011564385145902634, -0.005892440676689148], "changes": {"1wk": -7.272727666807574}}, {"text": "LIVE The latest news and updates on Trump's tariffs ALX Oncology to Present at the 43rd Annual J.P. Morgan Healthcare Conference ALX Oncology Tue, Jan 7, 2025, 4:00 PM 1 min read In This Article: ALXO ALX Oncology SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (\u201cALX Oncology\u201d) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives, today announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Chief Executive Officer, Jason Lettmann, will deliver a company overview presentation on Wednesday, January 15, 2025, at 3:00 p.m. Pacific Time. A live webcast of the presentation is available by clicking the link and can also be accessed by visiting the Investors section of ALX Oncology\u2019s website at www.alxoncology.com under the Events section of the News and Events tab. A replay of the webcast will be archived for up to 30 days following the presentation date. About ALX Oncology ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients\u2019 lives. ALX Oncology\u2019s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications. More information is available at www.alxoncology.com and on LinkedIn @ ALX Oncology . CONTACT: Company Contact: Caitlyn Doherty, Manager, Corporate Communications, ALX Oncology cdoherty@alxoncology.com (650) 466-7125 Media Contact: Audra Friis, Sam Brown, Inc. audrafriis@sambrown.com (917) 519-9577 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-07T16:00:00", "sentiment": {"score": 0.05457326117902994, "confidence": 0.06608938425779343, "probabilities": {"positive": 0.06608938425779343, "negative": 0.011516123078763485, "neutral": 0.9223945140838623}}, "embedding": [-0.08766712248325348, -0.040194321423769, -0.04407689720392227, -0.07140158116817474, -0.03203263878822327, -0.019071029499173164, -0.022374127060174942, 0.04120129719376564, 0.07148360460996628, -0.030347319319844246, -0.06692761927843094, 0.05115818977355957, 0.06456869840621948, 0.017511922866106033, -0.060227204114198685, 0.1706266552209854, 0.1264214962720871, -0.02665569633245468, -0.10334635525941849, 0.1394520252943039, 0.051757946610450745, 0.008028210140764713, 0.11522627621889114, 0.085221067070961, -0.045768074691295624, -0.03504880517721176, -0.09252501279115677, 0.026647452265024185, -0.1480901539325714, -0.07390130311250687, 0.05511864647269249, 0.09337977319955826, -0.010169065557420254, -0.12127875536680222, -0.036041490733623505, -2.5962283416447463e-06, -0.06457644701004028, 0.06412753462791443, -0.040103450417518616, -0.008828471414744854, 0.047677308320999146, -0.06891131401062012, -0.0747881829738617, 0.16929404437541962, -0.02776489406824112, -0.17051590979099274, -0.005386263597756624, -0.035447459667921066, 0.057419221848249435, 0.21279145777225494, -0.08780799806118011, -0.07536038011312485, -0.006722623948007822, 0.11232029646635056, -0.07278431951999664, 0.003704206319525838, -0.18392013013362885, 0.026160985231399536, 0.03681115806102753, -0.11059074103832245, -0.014138735830783844, -0.07091549038887024, 0.08333937078714371, 0.21952058374881744, 0.01948518492281437, 0.05148783698678017, -0.019517386332154274, -0.0465690903365612, -0.12243911623954773, -0.08785935491323471, 0.062224745750427246, -0.0976625382900238, 0.09435161203145981, 0.1228335052728653, 0.08321026712656021, 0.12140582501888275, 0.19701576232910156, 0.0055130585096776485, 0.07012569904327393, 0.010678229853510857, 0.0792444497346878, 0.10871297121047974, 0.08211972564458847, 0.05745190754532814, -0.03852203115820885, -0.059031613171100616, 0.0341331884264946, 0.11859344691038132, -0.030971819534897804, 0.0006335428333841264, 0.03499357029795647, 0.06508510559797287, -0.021163733676075935, 0.02824857458472252, 0.030391819775104523, -0.10715825855731964, -0.01886609196662903, 0.04868367686867714, 0.015273185446858406, 0.028280092403292656, 0.024524247273802757, -0.0053284685127437115, -0.04197137802839279, -0.0019741328433156013, -0.0671890377998352, -0.015873203054070473, -0.03969084843993187, -0.016481246799230576, -0.019823215901851654, -0.017001446336507797, -0.05764683708548546, -0.018581489101052284, -0.08590837568044662, -0.081863634288311, -0.031242087483406067, 0.2081102877855301, -0.06924989819526672, -0.10520976781845093, 0.11860734224319458, -0.09941548109054565, -0.039376672357320786, -0.10305177420377731, -0.031472355127334595, -0.028336206451058388, 0.10255304723978043, 0.11040114611387253, -0.08746343851089478, 9.290067771082852e-33, -0.1447872519493103, -0.1139727309346199, 0.07433349639177322, 0.01859004609286785, 0.05776485428214073, -0.05134087800979614, 0.09889153391122818, -0.054780181497335434, -0.21221867203712463, -0.0951233059167862, -0.09656073898077011, 0.1312316209077835, 0.1144460067152977, 0.05993677303195, -0.023364366963505745, -0.1747671514749527, -0.008102298714220524, 0.01764533668756485, -0.043677423149347305, -0.0171064306050539, 0.022006049752235413, -0.0403057225048542, -0.04468025267124176, 0.07786454260349274, -0.003440038301050663, 0.13983426988124847, 0.035490311682224274, 0.028289664536714554, -0.03031916543841362, 0.027733687311410904, -0.18479301035404205, 0.12044809013605118, -0.06630702316761017, -0.1128728836774826, -0.06068301945924759, 0.05619554594159126, -0.13945095241069794, -0.11334240436553955, 0.06788745522499084, -0.030211033299565315, -0.07412544637918472, 0.10975435376167297, -0.022817768156528473, -0.04292137920856476, 0.07064198702573776, -0.049367353320121765, -0.07208262383937836, -0.03779444471001625, 0.034184765070676804, 0.008657845668494701, 0.06978989392518997, 0.002824137918651104, -0.0343288816511631, -0.06811545044183731, -0.009592882357537746, -0.019038880243897438, -0.2378700226545334, 0.042531851679086685, 0.0313018262386322, 0.10316641628742218, -0.02366289682686329, 0.0474693663418293, -0.04378151893615723, 0.101401686668396, -0.10657777637243271, 0.07797935605049133, -0.03773188218474388, -0.16474762558937073, -0.017970537766814232, 0.06529974192380905, -0.038703106343746185, 0.015435515902936459, 0.15797898173332214, -0.010138326324522495, 0.0659235343337059, 0.019470971077680588, 0.03860071301460266, -0.013450794853270054, -0.0161577258259058, 0.15401622653007507, 0.025656407698988914, -0.030750136822462082, -0.050752073526382446, 0.11926820874214172, -0.07831963896751404, -0.09414118528366089, -0.058539554476737976, 0.026881547644734383, -0.0664328932762146, 0.0715411826968193, 0.10046125203371048, -0.020309187471866608, -0.009130212478339672, 0.08671503514051437, -0.001991520170122385, -1.0583311391027008e-32, 0.08166206628084183, -0.054034702479839325, 0.020655689761042595, -0.13732141256332397, -0.00706391129642725, 0.09712856262922287, 0.053637564182281494, -0.016095640137791634, 0.08842939883470535, -0.061284057796001434, 0.09863966703414917, 0.17288090288639069, 0.005513821262866259, 0.0027034226804971695, -0.12987565994262695, -0.04134679213166237, 0.008297927677631378, -0.11528271436691284, -0.07829366624355316, -0.02355046011507511, 0.10926269739866257, 0.251315176486969, -0.11297032982110977, -0.002197934314608574, -0.020594995468854904, 0.03198022395372391, 0.10565603524446487, 0.12252577394247055, 0.12221353501081467, -0.08771079778671265, -0.1276247352361679, 0.05961686000227928, -0.17266646027565002, 0.01091702375560999, 0.0798514261841774, 0.10487428307533264, 0.05910133570432663, -0.10351879894733429, -0.0192940104752779, -0.08480294793844223, 0.09116366505622864, -0.08086594194173813, -0.08928121626377106, 0.032615046948194504, 0.11677343398332596, 0.162960484623909, -0.021403076127171516, 0.017170216888189316, 0.12157664448022842, 0.02580271102488041, -0.0893675833940506, 0.09033062309026718, -0.03076218254864216, -0.00016654501087032259, 0.047588396817445755, 0.03362691029906273, -0.06799861043691635, -0.13659550249576569, -0.09091541171073914, -0.005733083933591843, 0.010451429523527622, 0.117367684841156, 0.10348843038082123, -0.037477005273103714, -0.02991275116801262, 0.133366659283638, 0.03291337192058563, -0.03822983428835869, 0.0006556531880050898, -0.00789274089038372, 0.0747215747833252, 0.021131018176674843, -0.17701978981494904, -0.07359769195318222, 0.06585942953824997, 0.053139470517635345, 0.06415873765945435, -0.14551150798797607, -0.1664351522922516, 0.029476620256900787, 0.005503506399691105, -0.05371394008398056, 0.04425174742937088, 0.06240257993340492, 0.11374349892139435, 0.13804104924201965, 0.00039781458326615393, 0.002334927674382925, -0.07793088257312775, 0.011709352023899555, -0.05438853055238724, -0.18941281735897064, -0.13324971497058868, 0.07918960601091385, -0.11559825390577316, -1.0015158125042944e-07, 0.04073812812566757, 0.0036248352844268084, 0.07108208537101746, -0.13324634730815887, -0.004598255734890699, 0.0465761199593544, -0.008874638006091118, 0.008295499719679356, 0.065232053399086, 0.11620286852121353, 0.15237092971801758, 0.13047778606414795, -0.07666376233100891, -0.0026032961905002594, -0.05013247951865196, 0.06083815172314644, -0.06371987611055374, -0.03389303758740425, -0.004028288181871176, -0.09039611369371414, -0.12570808827877045, -0.021089976653456688, 0.006626340094953775, 0.04251765459775925, 0.040963757783174515, -0.052802667021751404, -0.006667939946055412, 0.08789250999689102, 0.06245418265461922, -0.05566827580332756, -0.06403110176324844, -0.04962780699133873, -0.011274873279035091, -0.007994993589818478, -0.02979588322341442, -0.1400640606880188, 0.012294095009565353, 0.018556414172053337, 0.14207643270492554, 0.04100847616791725, 0.009511600248515606, 0.03381847217679024, 0.025146380066871643, 0.017335236072540283, -0.07006212323904037, 0.01620355062186718, -0.12080360949039459, -0.09718147665262222, 0.030316218733787537, -0.13784925639629364, 0.010825851932168007, -0.08448337763547897, -0.07191106677055359, -0.02010606974363327, -0.08082815259695053, 0.09720391780138016, -0.03450693562626839, -0.1287105679512024, 0.06307259202003479, -0.043121982365846634, 0.08296851068735123, -0.14878316223621368, 0.0742698386311531, 0.03803073987364769], "changes": {"1wk": -9.139782568666634}}, {"text": "LIVE The latest news and updates on Trump's tariffs Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year? Zacks Equity Research Tue, Jan 7, 2025, 5:40 PM 2 min read In This Article: ALXO For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. ALX Oncology Holdings Inc. (ALXO) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out. ALX Oncology Holdings Inc. is one of 1011 individual stocks in the Medical sector. Collectively, these companies sit at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ALX Oncology Holdings Inc. is currently sporting a Zacks Rank of #2 (Buy). Over the past three months, the Zacks Consensus Estimate for ALXO's full-year earnings has moved 11.1% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving. Based on the most recent data, ALXO has returned 7.2% so far this year. Meanwhile, the Medical sector has returned an average of -4.9% on a year-to-date basis. This means that ALX Oncology Holdings Inc. is outperforming the sector as a whole this year. Another stock in the Medical sector, Ginkgo Bioworks Holdings, Inc. (DNA), has outperformed the sector so far this year. The stock's year-to-date return is 18.6%. In Ginkgo Bioworks Holdings, Inc.'s case, the consensus EPS estimate for the current year increased 12% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, ALX Oncology Holdings Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 513 individual stocks and currently sits at #66 in the Zacks Industry Rank. This group has lost an average of 12.7% so far this year, so ALXO is performing better in this area. Ginkgo Bioworks Holdings, Inc. is also part of the same industry. Investors with an interest in Medical stocks should continue to track ALX Oncology Holdings Inc. and Ginkgo Bioworks Holdings, Inc. These stocks will be looking to continue their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ALX Oncology Holdings Inc. (ALXO) : Free Stock Analysis Report Story Continues Ginkgo Bioworks Holdings, Inc. (DNA) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-07T17:40:10", "sentiment": {"score": 0.8562426269054413, "confidence": 0.8765591382980347, "probabilities": {"positive": 0.8765591382980347, "negative": 0.020316511392593384, "neutral": 0.10312431305646896}}, "embedding": [-0.07347147166728973, -0.0924420952796936, 0.017956554889678955, 0.06233551725745201, -0.023857243359088898, -0.08244405686855316, -0.08991529047489166, 0.07085005193948746, 0.14143845438957214, 0.06028379499912262, -0.1194557398557663, 0.10796646028757095, 0.021305473521351814, -0.029801836237311363, -0.14667938649654388, 0.0689566358923912, 0.07545263320207596, 0.004264588467776775, -0.19276995956897736, 0.11147299408912659, -0.01652715727686882, -0.13176825642585754, 0.14630749821662903, 0.02630973793566227, 0.11602598428726196, -0.019742537289857864, -0.10556519776582718, 0.061967089772224426, -0.1576244831085205, -0.0782049149274826, -0.0313175767660141, 0.16454434394836426, 0.04314026981592178, -0.11707355827093124, -0.15142196416854858, -0.001093003898859024, -0.0295586958527565, 0.05365411192178726, 0.14976592361927032, 0.05559903755784035, 0.05155006796121597, 0.05234605446457863, -0.005233569070696831, 0.014936354011297226, -0.041562385857105255, -0.14535143971443176, -0.020083537325263023, -0.013291937299072742, 0.12389285862445831, 0.09674883633852005, -0.18795785307884216, -0.042067140340805054, 0.0076291244477033615, 0.09871841222047806, -0.09444063901901245, 0.0307460930198431, -0.1234581470489502, -0.07260443270206451, 0.05566076934337616, -0.00033974088728427887, 0.15229889750480652, 0.06496807187795639, 0.05276470631361008, 0.07953931391239166, 0.11011887341737747, -0.013726700097322464, -0.03509283810853958, -0.029253311455249786, -0.17917202413082123, 0.005232144147157669, 0.15473949909210205, -0.08603018522262573, -0.025691982358694077, 0.09027308225631714, -0.050329599529504776, 0.09226435422897339, 0.09184403717517853, 0.05790415033698082, 0.09520947933197021, -0.08065806329250336, 0.09354276955127716, -0.007071901578456163, 0.008769246749579906, -0.040389806032180786, -0.03295157849788666, -0.039675526320934296, 0.08896239846944809, 0.06458676606416702, -0.01496890839189291, 0.0415494441986084, 0.05318599194288254, -0.021162718534469604, 0.053205426782369614, -0.01040351577103138, 0.10136314481496811, 0.029515240341424942, 0.03832370042800903, 0.03846704214811325, -0.07988575100898743, 0.10398903489112854, 0.0946265310049057, 0.02347615733742714, -0.04705464839935303, -0.0776754692196846, -0.06064119189977646, -0.10344917327165604, 0.0038146590813994408, -0.02297738566994667, -0.00739399716258049, -0.018860599026083946, -0.025614600628614426, 0.16007119417190552, -0.17312343418598175, -0.032215625047683716, -0.13888978958129883, 0.05897035077214241, 0.021390561014413834, -0.047195080667734146, 0.10215364396572113, 0.07269307225942612, 0.047031715512275696, 0.034249305725097656, -0.00315994955599308, -0.001802339917048812, 0.10814360529184341, 0.013049808330833912, -0.1578013151884079, 7.626516982006782e-33, -0.018275750800967216, 0.04952372610569, 0.017684709280729294, -0.052687421441078186, -0.10013099759817123, 0.016399715095758438, 0.051954176276922226, -0.14971193671226501, -0.1505962312221527, -0.11505675315856934, -0.2306033968925476, 0.19435562193393707, -0.028521902859210968, -0.08204791694879532, 0.06597645580768585, -0.1265166848897934, -0.046057216823101044, 0.02387496456503868, -0.04605625569820404, -0.07220066338777542, 0.03971052169799805, 0.016538292169570923, -0.1329713612794876, -0.005455102771520615, 0.007264441344887018, -0.05065545067191124, -0.07491708546876907, -0.07356825470924377, -0.20546488463878632, 0.03975377976894379, -0.005704999435693026, 0.05970597267150879, -0.09823022037744522, -0.1418459713459015, -0.026522397994995117, -0.08025560528039932, -0.062344640493392944, 0.014479375444352627, 0.13026173412799835, -0.04163539409637451, -0.13552342355251312, 0.11231780052185059, -0.12464949488639832, -0.08133096992969513, 0.025204624980688095, 0.037202052772045135, -0.17307516932487488, -0.018471475690603256, 0.007909012027084827, 0.012481124140322208, -0.05695280432701111, 0.028189707547426224, 0.060538921505212784, -0.053256094455718994, -0.04784448444843292, 0.006699498742818832, -0.0677296593785286, -0.08323172479867935, 0.020580247044563293, 0.12651899456977844, 0.051671065390110016, 0.13307973742485046, -0.003822693135589361, 0.02898862585425377, -0.21861904859542847, 0.11669658124446869, 0.024661293253302574, 0.019324854016304016, -0.048100609332323074, 0.1633422076702118, -0.008568482473492622, 0.008445743471384048, 0.1415533423423767, -0.057675112038850784, 0.052952639758586884, -0.03370719030499458, -0.03189601004123688, 0.015999745577573776, -0.051577601581811905, 0.08961376547813416, 0.09250202029943466, -0.07486633956432343, -0.05877317488193512, -0.002209216821938753, -0.04677293077111244, -0.04489944875240326, -0.0026965131983160973, -0.015895234420895576, -0.04195273667573929, 0.06839630007743835, -0.029307324439287186, -0.025722812861204147, -0.03229755908250809, 0.046605754643678665, 0.07924430817365646, -8.356931702725319e-33, -0.014001723378896713, -0.008184097707271576, 0.1268545240163803, -0.08382034301757812, -0.04659412056207657, 0.006884673610329628, 0.0697188526391983, 0.01779954880475998, -0.06003982946276665, -0.04471597075462341, 0.06485925614833832, 0.13749679923057556, -0.0651109516620636, 0.01838282123208046, -0.038924116641283035, 0.03375272825360298, 0.006325859110802412, -0.09237805008888245, 0.0401189848780632, -0.09301905333995819, 0.05366986244916916, 0.23121263086795807, -0.1270361691713333, 0.17984551191329956, -0.016942190006375313, 0.029466312378644943, -0.066202811896801, 0.14238029718399048, 0.06169061362743378, -0.11909480392932892, -0.07183900475502014, 0.03126085549592972, -0.10635129362344742, 0.10150304436683655, -0.00457334890961647, 0.07382605224847794, 0.010199042037129402, -0.18580657243728638, -0.047682639211416245, -0.0012117251753807068, 0.17238715291023254, -0.02529791370034218, 0.004200476687401533, 0.011078614741563797, 0.13507215678691864, 0.11845578253269196, 0.0013226736336946487, 0.04516913741827011, 0.16788820922374725, 0.02045200765132904, -0.01931963674724102, 0.09623689204454422, -0.10116420686244965, 0.18652313947677612, -0.04041224718093872, 0.07990559935569763, -0.12169177085161209, -0.040990106761455536, -0.21887655556201935, 0.021002039313316345, 0.008431080728769302, 0.12860220670700073, 0.009342450648546219, 0.01052219420671463, -0.09182815998792648, 0.010784615762531757, -0.050847895443439484, -0.08262380212545395, 0.005470192525535822, -0.001616201363503933, 0.027621891349554062, -0.07748154550790787, 0.002184966579079628, -0.1067262813448906, 0.033213336020708084, 0.22394722700119019, 0.016774650663137436, -0.1244342252612114, -0.1791868805885315, 0.03129252418875694, 0.07757097482681274, 0.08137645572423935, 0.09378895163536072, 0.028177576139569283, -0.06954219937324524, 0.20660415291786194, 0.07028912007808685, -0.05313827097415924, -0.1228937953710556, -0.07137493789196014, -0.04900377243757248, -0.21158969402313232, -0.127174511551857, -0.05592372268438339, -0.019962411373853683, -1.0015507001526203e-07, 0.020461617037653923, -0.09662798047065735, 0.07748781889677048, -0.07232861965894699, 0.046958476305007935, 0.014408991672098637, -0.055645667016506195, 0.05523182451725006, 0.10271480679512024, 0.09924189746379852, 0.21475571393966675, 0.04116268828511238, -0.2608458399772644, 0.02815128117799759, -0.06633365154266357, 0.05477006733417511, -0.13006539642810822, 0.0485583171248436, 0.02980155497789383, -0.12747040390968323, -0.0035544559359550476, 0.05007365345954895, 0.17473860085010529, 0.027507536113262177, 0.06807868182659149, 0.055226340889930725, -0.11372151970863342, -0.05444991588592529, 0.04412834718823433, 0.1587098389863968, 0.09093805402517319, -0.0915689766407013, 0.048382021486759186, 0.03879191726446152, 0.04224282130599022, -0.03507689759135246, 0.033531758934259415, 0.05097488313913345, 0.050506241619586945, 0.01900302991271019, 0.07573100924491882, -0.007417209446430206, -0.011873340234160423, 0.0380781888961792, -0.025877850130200386, -0.06848478317260742, -0.04026580601930618, 0.002940261969342828, 0.18701863288879395, -0.23582524061203003, 0.09157104790210724, -0.16024449467658997, -0.05373930186033249, 0.038762304931879044, -0.02643962949514389, 0.04598087817430496, -0.1479577124118805, -0.008276201784610748, -0.10037634521722794, -0.03362422063946724, 0.13419225811958313, -0.16593588888645172, 0.06406591087579727, 0.17632313072681427], "changes": {"1wk": -14.516127895159403}}, {"text": "LIVE The latest news and updates on Trump's tariffs 3 US Penny Stocks With Market Caps Under $100M To Watch editorial-team@simplywallst.com (Simply Wall St) Wed, Jan 8, 2025, 11:05 PM 4 min read In This Article: ALXO As the U.S. stock market experiences fluctuations, with major indices showing slight gains and losses, investors are keeping a close eye on economic indicators that could influence interest rate decisions. Amidst these market dynamics, penny stocks continue to capture attention for their potential growth opportunities at lower price points. Although often associated with smaller or newer companies, these stocks can offer significant upside when backed by strong financials and solid fundamentals. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating BAB (OTCPK:BABB) $0.7975 $5.81M \u2605\u2605\u2605\u2605\u2605\u2605 Inter & Co (NasdaqGS:INTR) $4.39 $1.85B \u2605\u2605\u2605\u2605\u2606\u2606 QuantaSing Group (NasdaqGM:QSG) $3.08 $105.8M \u2605\u2605\u2605\u2605\u2605\u2605 Kiora Pharmaceuticals (NasdaqCM:KPRX) $3.9352 $11.7M \u2605\u2605\u2605\u2605\u2605\u2605 ZTEST Electronics (OTCPK:ZTST.F) $0.32 $11.12M \u2605\u2605\u2605\u2605\u2605\u2605 Golden Growers Cooperative (OTCPK:GGRO.U) $4.50 $67.38M \u2605\u2605\u2605\u2605\u2605\u2605 BTCS (NasdaqCM:BTCS) $2.57 $48.06M \u2605\u2605\u2605\u2605\u2605\u2605 Zynerba Pharmaceuticals (NasdaqCM:ZYNE) $1.30 $65.6M \u2605\u2605\u2605\u2605\u2605\u2606 Smith Micro Software (NasdaqCM:SMSI) $1.63 $32.99M \u2605\u2605\u2605\u2605\u2605\u2606 CBAK Energy Technology (NasdaqCM:CBAT) $1.02 $93.54M \u2605\u2605\u2605\u2605\u2605\u2606 Click here to see the full list of 724 stocks from our US Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. ALX Oncology Holdings Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing cancer therapies in the United States, with a market cap of approximately $94.41 million. Operations: ALX Oncology Holdings Inc. has not reported any revenue segments as it is a clinical-stage company focused on developing cancer therapies. Market Cap: $94.41M ALX Oncology Holdings Inc., a pre-revenue clinical-stage company, focuses on developing cancer therapies. Recent promising results from its Phase 1b/2 trial of evorpacept in combination with Jazz Pharmaceuticals\u2019 zanidatamab have shown significant anti-tumor activity in heavily pretreated breast cancer patients. Despite being removed from the NASDAQ Biotechnology Index, the company maintains a strong cash position with short-term assets of US$155.9 million exceeding liabilities and more cash than debt. However, it faces challenges such as high volatility and shareholder dilution over the past year while remaining unprofitable without near-term profitability forecasts. Navigate through the intricacies of ALX Oncology Holdings with our comprehensive balance sheet health report here. Assess ALX Oncology Holdings' future earnings estimates with our detailed growth reports. NasdaqGS:ALXO Debt to Equity History and Analysis as at Jan 2025 DUKE Robotics Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Story Continues Overview: DUKE Robotics Corp. operates as a robotics company with a market cap of $13.55 million. Operations: DUKR has not reported any revenue segments. Market Cap: $13.55M DUKE Robotics Corp., a pre-revenue company with a market cap of US$13.55 million, has experienced increased volatility, with weekly fluctuations rising from 69% to 91% over the past year. Despite being unprofitable and reporting minimal revenue (US$372K), it has improved its financial position by transitioning from negative to positive shareholder equity over five years. The firm maintains more cash than debt and covers both short- and long-term liabilities with assets totaling US$1.6 million. Recent changes include a corporate name update from UAS Drone Corp., effective November 2024, alongside stable board and management tenure averaging over six years. Take a closer look at DUKE Robotics' potential here in our financial health report. Examine DUKE Robotics' past performance report to understand how it has performed in prior years. OTCPK:DUKR Debt to Equity History and Analysis as at Jan 2025 Investview Simply Wall St Financial Health Rating: \u2605\u2605\u2605\u2605\u2605\u2605 Overview: Investview, Inc. operates through its subsidiaries to offer financial products and services focusing on financial education, digital assets, and related technology for individuals, with a market cap of $24.17 million. Operations: The company generates revenue primarily from its Online Financial Information Providers segment, totaling $58.45 million. Market Cap: $24.17M Investview, Inc., with a market cap of US$24.17 million, has shown financial improvement by transitioning from negative to positive shareholder equity over five years. The company became profitable recently, though it faced a large one-off loss of US$3.3 million impacting its last 12 months' results. Despite declining revenue and net income in the recent quarter compared to the previous year, Investview's debt is well covered by operating cash flow and short-term assets exceed liabilities. The board and management are experienced, and a share repurchase program was announced to reduce outstanding shares by approximately 6.5%. Dive into the specifics of Investview here with our thorough balance sheet health report. Review our historical performance report to gain insights into Investview's track record. OTCPK:INVU Financial Position Analysis as at Jan 2025 Next Steps Dive into all 724 of the US Penny Stocks we have identified here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Interested In Other Possibilities? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value . This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:ALXO OTCPK:DUKR and OTCPK:INVU. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "ALXO", "date": "2025-01-08T23:05:26", "sentiment": {"score": 0.0672556459903717, "confidence": 0.0859200730919838, "probabilities": {"positive": 0.0859200730919838, "negative": 0.01866442710161209, "neutral": 0.8954154849052429}}, "embedding": [-0.011243571527302265, -0.09631074965000153, -0.03106960654258728, -0.02016289532184601, 0.022524548694491386, -0.018288681283593178, 0.018208332359790802, 0.04782063513994217, 0.07983000576496124, -0.031717218458652496, -0.06999142467975616, 0.020082693547010422, 0.018634982407093048, -0.009447306394577026, -0.11096689105033875, 0.036311451345682144, 0.07564911246299744, 0.01993642747402191, -0.03635876998305321, 0.0786919891834259, -0.09442747384309769, -0.06950359046459198, 0.07745955884456635, 0.04385510832071304, 0.022787006571888924, 0.012689333409070969, -0.00043514184653759, 0.011329280212521553, -0.21090897917747498, -0.1551019251346588, -0.03387078642845154, 0.06836256384849548, 0.06395736336708069, -0.14901673793792725, -0.06394392997026443, -0.032735224813222885, 0.06636863946914673, 0.1003679484128952, 0.06927711516618729, -0.017492417246103287, 0.03364255279302597, -0.02581864222884178, -0.025506632402539253, 0.0376906543970108, 0.039242975413799286, -0.14874699711799622, -0.05092431604862213, 0.0165681391954422, 0.11181244254112244, 0.10990753769874573, -0.051878783851861954, 0.0620824359357357, 0.04695473238825798, 0.07662314921617508, -0.13153187930583954, 0.07053647935390472, -0.09912236034870148, 0.07188230752944946, 0.08789131045341492, -0.01972639188170433, 0.02084924280643463, -0.02645650878548622, 0.0235607847571373, 0.015676725655794144, 0.14559070765972137, 0.02967596799135208, -0.09014187008142471, -0.04867032170295715, -0.08287355303764343, -0.09710141271352768, 0.06480474025011063, -0.08588674664497375, -0.07205864787101746, -0.011171102523803711, -0.07278822362422943, 0.11277803778648376, 0.11761774122714996, -0.017577731981873512, 0.05372853949666023, 0.02891368605196476, -0.07782430946826935, -0.0749691054224968, 0.08719274401664734, -0.03550625219941139, -0.018000032752752304, -0.022983621805906296, 0.07247386872768402, 0.03384854272007942, -0.009329354390501976, -0.06927265971899033, 0.06794797629117966, 0.031253982335329056, -0.06945783644914627, 0.007059995550662279, -0.033769529312849045, -0.031183183193206787, -0.06335055828094482, 0.04386187717318535, -0.10652472078800201, 0.06949780136346817, 0.22451484203338623, -0.07502105832099915, -0.07280765473842621, -0.03761862590909004, -0.00910249911248684, -0.08556254208087921, 0.058455273509025574, -0.0960034728050232, 0.0029053743928670883, 0.033618032932281494, 0.008247865363955498, 0.0872357040643692, -0.10290314257144928, -0.07517945766448975, -0.12896381318569183, -0.011146420612931252, -0.08689314126968384, -0.1215868890285492, 0.1027623862028122, -0.008959298022091389, 0.03155871480703354, 0.033388834446668625, -0.1324682980775833, 0.03427083417773247, -0.036038901656866074, 0.027591893449425697, -0.062134772539138794, 1.6656443445148846e-32, -0.13397882878780365, 0.023934463039040565, -0.033416006714105606, -0.10318253934383392, -0.06888420879840851, 0.04181528463959694, 0.04621906206011772, -0.08250366151332855, -0.15143084526062012, -0.060789041221141815, -0.11653299629688263, 0.1355571746826172, -0.06281750649213791, -0.020891958847641945, -0.05435994639992714, -0.2083238661289215, 0.00848839245736599, 0.016607381403446198, 0.029754023998975754, -0.07771642506122589, -0.03456515818834305, 0.12689433991909027, -0.12995260953903198, 0.04991157725453377, 0.01288685668259859, 0.03325032442808151, -0.07257001101970673, -0.10157476365566254, -0.015296714380383492, 0.037607599049806595, 0.0011720899492502213, 0.1165158599615097, -0.005837991833686829, -0.09848280251026154, -0.10849665105342865, -0.03441669046878815, -0.11817144602537155, -0.03327246010303497, 0.0072700632736086845, -0.0704340934753418, -0.07837118208408356, 0.1575920581817627, -0.08101843297481537, 0.047716137021780014, 0.0020325016230344772, 0.05007101222872734, -0.08280631899833679, 0.07302787899971008, 0.06500823050737381, -0.15583202242851257, -0.11000554263591766, -0.008076426573097706, -0.04774974286556244, 0.021733026951551437, 0.01641402766108513, -0.0005415603518486023, -0.06686175614595413, -0.11496242880821228, 0.015694333240389824, 0.10871163010597229, 0.059326447546482086, 0.1010919064283371, -0.08312050253152847, -0.0056226542219519615, -0.19709700345993042, 0.1261666715145111, 0.040399953722953796, 0.05363607406616211, -0.12474674731492996, 0.20362481474876404, -0.0309554785490036, -0.005513068288564682, 0.22975951433181763, 0.061207592487335205, 0.09451940655708313, -0.031155608594417572, -0.005780462175607681, -0.013839330524206161, 0.023510145023465157, -0.039553944021463394, 0.06649316102266312, -0.10280561447143555, 0.0695781484246254, 0.06758683174848557, -0.024021951481699944, -0.026345759630203247, -0.07125174254179001, 0.02171625941991806, -0.015397081151604652, -0.04193544015288353, 0.002441396936774254, -0.041550833731889725, 0.04582877829670906, 0.057475194334983826, -0.05813636630773544, -1.7608111916631062e-32, -0.02149869129061699, -0.059068843722343445, 0.001876523718237877, -0.01672603189945221, -0.046432074159383774, 0.012918861582875252, 0.008434871211647987, -0.05825808271765709, 0.04158370941877365, -0.03902454301714897, -0.011992007493972778, 0.06694797426462173, -0.04863905906677246, 0.02709607407450676, -0.046993937343358994, 0.06191512197256088, 0.012658633291721344, -0.027857890352606773, 0.028678009286522865, -0.1407310962677002, -0.13940338790416718, 0.16007880866527557, -0.1401631385087967, 0.10593119263648987, -0.022883137688040733, 0.019406955689191818, -0.0050311703234910965, 0.06392836570739746, 0.05140025168657303, 0.03978722542524338, -0.18877264857292175, 0.03869457542896271, -0.09485841542482376, 0.10511492192745209, -0.046753399074077606, 0.10152162611484528, 0.03015385940670967, -0.08081287145614624, -0.05125228315591812, 0.04861091077327728, 0.048706162720918655, -0.03799908980727196, 0.060799144208431244, 0.04089205712080002, 0.09501759707927704, 0.03893720731139183, -0.019976019859313965, 0.06554847210645676, 0.03712654113769531, 0.14398454129695892, -0.014580445364117622, 0.08707792311906815, 0.03369525074958801, 0.10090935975313187, -0.11645200848579407, 0.06311429291963577, -0.021612634882330894, 0.006239321082830429, -0.09054586291313171, -0.02722514048218727, -0.034318957477808, 0.15846559405326843, 0.07949557900428772, 0.03744760900735855, -0.056683313101530075, 0.08096173405647278, -0.07912345230579376, 0.017488669604063034, -0.02293483167886734, -0.08510782569646835, 0.026200268417596817, -0.0049092136323452, 0.0743698924779892, -0.15700358152389526, 0.013482538983225822, 0.18533581495285034, -0.002193581312894821, -0.003782769199460745, -0.03035600669682026, 0.12891265749931335, -0.02505846507847309, 0.09219437092542648, 0.036739833652973175, 0.06282337754964828, 0.027589622884988785, 0.1363331377506256, -0.03424737602472305, 0.010508731007575989, -0.07346541434526443, -0.016195522621273994, -0.024616647511720657, -0.1032809466123581, 0.001829473301768303, -0.016241829842329025, -0.09247413277626038, -1.0057446786504443e-07, 0.04958159849047661, -0.10688910633325577, 0.010022696107625961, -0.02054705284535885, 0.06621590256690979, 0.06065327301621437, 0.057003170251846313, 0.019761400297284126, 0.05120920389890671, 0.17613258957862854, 0.13956229388713837, 0.09725898504257202, -0.23487535119056702, -0.023559972643852234, -0.09209424257278442, -0.016227424144744873, -0.030780382454395294, 0.1056811511516571, 0.008420513942837715, -0.006144630257040262, -0.01814783364534378, 0.15004953742027283, 0.07665078341960907, -0.038683027029037476, 0.04061751067638397, 0.05177086591720581, -0.034659773111343384, 0.03738630935549736, 0.07679998129606247, 0.10353682935237885, -0.009304639883339405, -0.026762543246150017, 0.04263845831155777, -0.06035502627491951, 0.11558739840984344, 0.05086624622344971, -0.036975957453250885, 0.09992603212594986, 0.06334585696458817, 0.035222671926021576, -0.011850856244564056, -0.07461351901292801, -0.005585775710642338, -0.023360058665275574, 0.05616021901369095, -0.04650120437145233, -0.10623042285442352, 0.00789619144052267, 0.187755286693573, -0.1769304871559143, -0.023040620610117912, -0.06288937479257584, -0.05695374310016632, 0.012401137501001358, 0.039852868765592575, 0.09304816275835037, -0.15739378333091736, -0.0496520921587944, -0.05010734125971794, -0.016276217997074127, 0.08965125679969788, -0.24246767163276672, 0.06998425722122192, 0.10581997036933899], "changes": {"1wk": -11.891893285134119}}]